<SEC-DOCUMENT>0001040130-24-000081.txt : 20240808
<SEC-HEADER>0001040130-24-000081.hdr.sgml : 20240808
<ACCEPTANCE-DATETIME>20240808171904
ACCESSION NUMBER:		0001040130-24-000081
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240808
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240808
DATE AS OF CHANGE:		20240808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PETMED EXPRESS INC
		CENTRAL INDEX KEY:			0001040130
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				650680967
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28827
		FILM NUMBER:		241189677

	BUSINESS ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
		BUSINESS PHONE:		(561) 426-4444

	MAIL ADDRESS:	
		STREET 1:		420 SOUTH CONGRESS AVENUE
		CITY:			DELRAY BEACH
		STATE:			FL
		ZIP:			33445
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>pets-20240808.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:270fcfd2-e9f9-4153-be8a-0c4ee1f4cdd2,g:ff2e6c25-9265-4d81-8a2c-4b3c972b0ebd,d:973380856cff46449ad53faf084dfb85-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pets-20240808</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001040130</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pets-20240808.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001040130</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-08</xbrli:startDate><xbrli:endDate>2024-08-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i973380856cff46449ad53faf084dfb85_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">August 8, 2024</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">PetMed Express, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Florida</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">000-28827</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">65-0680967</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other jurisdiction</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of incorporation)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">420 South Congress Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Delray Beach</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Florida</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">33445</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">561</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">526-4444</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:1.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trading Symbol(s)</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">PETS</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">NASDAQ Global Select Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div></div><div id="i973380856cff46449ad53faf084dfb85_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On August&#160;8, 2024, the shareholders of PetMed Express, Inc. (the &#8220;Company&#8221;), upon recommendation of the Company&#8217;s Board of Directors (&#8220;Board&#8221;), approved the PetMed Express, Inc. 2024 Omnibus Incentive Plan (&#8220;2024 Plan&#8221;). The 2024 Plan is described in greater detail in proposal 3 in the Company&#8217;s Proxy Statement on Schedule 14A for the Company&#8217;s 2024 Annual Meeting of Shareholders (&#8220;Proxy Statement&#8221;). The Proxy Statement, which includes an appendix with a full copy of the 2024 Plan, was filed with the U.S. Securities and Exchange Commission on June 24, 2024. The descriptions of the 2024 Plan contained herein and in the Proxy Statement are qualified in their entirety by reference to the full text of the 2024 Plan set forth in Exhibit 10.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">In connection with the approval of the 2024 Plan, and effective on August&#160;8, 2024, the Board approved certain amendments to the Company&#8217;s program for the compensation of non-employee directors, which amendments include that annual awards of restricted stock units to non-employee directors will be under the 2024 Plan, and other clarifications or non-substantive changes.</span></div><div style="margin-bottom:0.08pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i973380856cff46449ad53faf084dfb85_75"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Item 5.07 Submission of Matters to a Vote of Security Holders.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On August&#160;8, 2024, the Company held its Annual Meeting of Shareholders (&#8220;Annual Meeting&#8221;). The proposals presented at the Annual Meeting are described in more detail in the Company&#8217;s Proxy Statement. As of June&#160;12, 2024, the record date for the Annual Meeting, there were 20,609,192 shares of the Company&#8217;s voting securities issued and outstanding and eligible to be voted at the Annual Meeting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A total of 15,734,719 shares were represented in person or by proxy at the Annual Meeting, which constituted a quorum to conduct business at the Annual Meeting. With a majority of the outstanding shares voting either by proxy or in person, the Company&#8217;s shareholders cast their votes as described below.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Proposal 1 - The six director nominees proposed by the Company&#8217;s Board were elected to serve as members of the Board until the next annual meeting of shareholders and until their respective successors have been duly elected and qualified by the following final voting results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.030%"><tr><td style="width:1.0%"/><td style="width:19.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.882%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.736%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Against</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Abstentions</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Broker Non-Votes</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Leslie C.G. Campbell</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,394,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,568,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">61,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sandra Y. Campos</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,629,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">334,004&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">61,031&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gian M. Fulgoni</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">8,972,142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,988,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">63,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Justin Mennen</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,526,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">435,537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">62,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Diana Garvis Purcel</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">9,647,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1,316,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">59,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Leah A. Solivan</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,519,247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">444,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">60,660&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Proposal 2 - The Company&#8217;s shareholders approved, on an advisory basis, the compensation of the Company&#8217;s named executive officers named in the Proxy Statement by the following final voting results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.757%"><tr><td style="width:1.0%"/><td style="width:24.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.631%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Against</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Abstentions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,078,516</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">871,696</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">73,883</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,624</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Proposal 3 - The Company&#8217;s shareholders approved the PetMed Express, Inc. 2024 Omnibus Incentive Plan by the following final voting results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.757%"><tr><td style="width:1.0%"/><td style="width:24.518%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.920%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.631%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.390%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.224%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Against</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Abstentions</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Broker Non-Votes</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10,205,700</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">701,519</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">116,878</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4,710,622</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Proposal 4 - The Company&#8217;s shareholders ratified the appointment of RMS US LLP as the Company&#8217;s independent registered public accounting firm for fiscal year 2025 by the following final voting results:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.181%"><tr><td style="width:1.0%"/><td style="width:30.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.554%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.557%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">For</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Against</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Abstentions</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">15,266,297</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">368,629</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">99,793</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div><span><br/></span></div><div id="i973380856cff46449ad53faf084dfb85_81"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.606%"><tr><td style="width:1.0%"/><td style="width:9.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.910%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:84.854%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:center"><span><br/></span></div><div style="margin-bottom:0.08pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Description</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1012024omnibusincen.htm">PetMed Express, Inc. 2024 Omnibus Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.1.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1011formofrsuaward.htm">Form of Restricted Stock Unit A</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1011formofrsuaward.htm">ward</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1011formofrsuaward.htm"> under 2024 Omnibus Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.1.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1012formofpsuaward.htm">Form of Performance Stock Unit A</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1012formofpsuaward.htm">ward</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1012formofpsuaward.htm"> under 2024 Omnibus Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.1.3</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1013formofrsa.htm">Form of Restricted Stock A</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1013formofrsa.htm">ward</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1013formofrsa.htm"> under 2024 Omnibus Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">10.1.4</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1014formofstockopti.htm">Form of </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1014formofstockopti.htm">Stock </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1014formofstockopti.htm">Option A</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1014formofstockopti.htm">ward under the 2024 Omnibus Incentive Plan</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit1014formofstockopti.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">10.2</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit102non-employeedire.htm">Non-Employee Director Compensation Program, revised as of August 8, 2024.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">3</span></div></div></div><div id="i973380856cff46449ad53faf084dfb85_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:0.08pt"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: August&#160;8, 2024</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.415%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.416%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PETMED EXPRESS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">/s/ Sandra Y. Campos</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sandra Y. Campos</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chief Executive Officer and President</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">4</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit1012024omnibusincen.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i226bd4d80e1c4acda317a2be79ada3a4_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PETMED EXPRESS, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2024 OMNIBUS INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Purpose&#59; Effective Date&#59; Effect on Prior Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Purpose</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The PetMed Express, Inc. 2024 Omnibus Incentive Plan (the &#8220;Plan&#8221;) has two complementary purposes&#58; (i) to attract and retain outstanding individuals to serve as officers, directors, employees, and consultants, and (ii) to increase stockholder value. The Plan will provide participants incentives to increase stockholder value by offering the opportunity to acquire shares of the Company&#8217;s common stock, receive monetary payments based on the value of such common stock, or receive other incentive compensation, on the potentially favorable terms that this Plan provides.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Plan will become effective, and Awards may be granted under this Plan, on and after the Effective Date.  The Plan will terminate as provided in Section 15. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">Effect on Prior Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Prior to the Effective Date, the Company had in effect the Prior Plans.  On the Effective Date, the Prior Plans terminated such that no new awards could be granted thereunder, although awards granted prior to the Approval Date under a Prior Plan and still outstanding as of the Effective Date will continue to be subject to all the terms and conditions of the Prior Plan.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Capitalized terms used and not otherwise defined in this Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">or in any Award agreement have the following meanings&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Administrator</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Board or the Committee&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, to the extent the Board or the Committee has delegated authority and responsibility as an Administrator of the Plan to one or more committees or officers of the Company as permitted by Section&#160;3(b), the term &#8220;Administrator&#8221; shall also mean such committee(s) and&#47;or officer(s).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning ascribed to such term in Rule 12b-2 under the Exchange Act. Notwithstanding the foregoing, for purposes of determining those individuals to whom an Option or a Stock Appreciation Right may be granted, the term &#8220;Affiliate&#8221; means any entity that, directly or through one or more intermediaries, is controlled by or is under common control with, the Company within the meaning of Code Sections 414(b) or (c)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in applying such provisions, the phrase &#8220;at least 20 percent&#8221; shall be used in place of &#8220;at least 80 percent&#8221; each place it appears therein. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Applicable Exchange</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the national securities exchange or automated trading system on which the Stock is principally traded at the applicable time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a grant of Options, Stock Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Stock Units, Stock, a Cash Incentive Award, or any other type of award permitted under this Plan. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cash Incentive Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a right  to receive a cash payment to the extent Performance Goals are achieved (or other requirements are met), as described in Section 10.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, with respect to a Participant, one of the following, which are listed in order of priority&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">the meaning given in a Participant&#8217;s employment, retention, change of control, severance or similar agreement with the Company or any Affiliate&#59; or if none then</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the meaning given in the Award agreement&#59; or if none then</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">the meaning given in the Company&#8217;s employment policies as in effect at the time of the determination (or if the determination of Cause is being made within two years following a Change of Control, the meaning given in the Company&#8217;s employment policies as in effect immediately prior to the Change of Control)&#59; or if none then</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">the occurrence of any of the following&#58; (x) the repeated failure or refusal of the Participant to follow the lawful directives of the Company or an Affiliate (except due to sickness, injury or disabilities), (y) gross inattention to duty or any other willful, reckless or grossly negligent act (or omission to act) by the Participant, which, in the good faith judgment of the Company, could result in a material injury to the Company or an Affiliate including but not limited to the repeated failure to follow the policies and procedures of the Company, or (z) the commission by the Participant of a felony or other crime involving moral turpitude or the commission by the Participant of an act of financial dishonesty against the Company or an Affiliate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">A &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall have the meaning given in an Award agreement, or if none, shall be deemed to exist if any of the following occurs&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">any person, as such term is used in Sections 13(d)(3) and 14(d)(2) of the Exchange Act, becomes a beneficial owner (within the meaning of Rule 13d-3 under such Act) of 20% or more of the Company's outstanding Stock&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">within any 24 month period, the persons who were directors of the Company immediately before the beginning of such period (the &#8220;Incumbent Directors&#8221;) shall cease (for any reason other than death) to constitute at least a majority of the Board or the board of directors of any successor to the Company, provided that any director who was not a director at the beginning of such period shall be deemed to be an Incumbent Director if such director (A) was elected to the Board by, or on the recommendation of or with the approval of, at least two-thirds of the directors who then qualified as Incumbent Directors either actually or by prior operation of this Section 2(h)(ii), and (B) was not designated by a person who has entered into an agreement with the Company to effect a transaction described in Section 2(h)(iii)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">the Company is merged, consolidated or reorganized into or with, or sells all or substantially all of its assets to, another company or other entity, and immediately after such transaction less than 80% of the voting power of the then-outstanding securities of such company or other entity immediately after such transaction is held in the aggregate by holders of the Stock immediately before such transaction.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an Award is considered deferred compensation subject to the provisions of Code Section 409A (whether by its terms or a result of a valid deferral election) and is payable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">upon a Change of Control, then the foregoing definition shall be deemed amended to the minimum extent necessary to comply with Code Section 409A, and the Administrator may include such amended definition in the Award agreement issued with respect to such Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Internal Revenue Code of 1986, as amended. Any reference to a specific provision of the Code includes any successor provision and the regulations promulgated under such provision. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee of the Board, any successor committee thereto or such other committee of the Board that is designated by the Board with the same or similar authority. The Committee shall consist only of Non-Employee Directors (not fewer than two (2)) who meet the definition of &#8220;non-employee director&#8221; under Rule 16b-3(b)(3) promulgated under the Exchange Act to the extent necessary for the Plan and Awards to comply with Rule 16b-3 promulgated under the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means PetMed Express, Inc., a Florida corporation, or any successor thereto. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a member of the Board. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.52pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a Participant&#8217;s inability to substantially perform his or her duties in his or her normal and regular manner, with reasonable accommodation, for more than ninety (90) days (whether consecutive or not) in any twelve (12) month period, as evidenced by a certificate signed either by a physician mutually acceptable to the Company and employee or, if the parties cannot agree, by a physician selected by agreement of a physician designated by the Company and a physician designated by the Participant.  The Participant shall submit to a reasonable number of examinations by the physician making the determination of Disability, and the Participant hereby authorizes the disclosure and release of all supporting medical records to the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Dividend Equivalent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the right to receive a payment, in cash or Shares, equal to the cash dividends or other cash distributions paid with respect to a Share.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means August 8, 2024, contingent on the Company&#8217;s shareholders approving the Plan at the Annual Meeting of Shareholders taking place on such date. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(p)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the Securities Exchange Act of 1934, as amended. Any reference to a specific provision of the Exchange Act includes any successor provision and the regulations and rules promulgated under such provision. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(q)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means, per Share on a particular date, a price that is based on the opening, closing, actual, high or low sale price, or the arithmetic mean of selling prices of, a Share, on the Applicable Exchange on the applicable date, the preceding trading day, the next succeeding trading day, or the arithmetic mean of selling prices on all trading days over a specified averaging period weighted by volume of trading on each trading day in the period that is within 30 days before or 30 days after the applicable date, as determined by the Board or the Committee in its discretion&#59; provided that, if an arithmetic mean of prices is used to set a grant price or an exercise price for an Option or Stock Appreciation Right, the commitment to grant the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">applicable Award based on such arithmetic mean must be irrevocable before the beginning of the specified averaging period in accordance with Treasury Regulation &#167;1.409A-1(b)(5)(iv)(A). The method of determining Fair Market Value with respect to an Award shall be determined by the Board or the Committee and may differ depending on whether Fair Market Value is in reference to the grant, exercise, vesting, settlement, or payout of an Award&#59; provided that, if the Board or the Committee does not specify a different method, the Fair Market Value of a Share as of a given date shall be the closing sale price as of the trading day immediately preceding the date as of which Fair Market Value is to be determined or, if there shall be no such sale on such date, the next preceding day on which such a sale shall have occurred. If the Stock is not traded on an established stock exchange, the Committee shall determine in good faith the Fair Market Value in whatever manner it considers appropriate, but based on objective criteria. Notwithstanding the foregoing, in the case of an actual sale of Shares, the actual sale price shall be the Fair Market Value of such Shares. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(r)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Non-Employee Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a Director who is not also an employee of the Company or its Subsidiaries.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the right to purchase Shares at a stated price for a specified period of time. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(t)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means an individual selected by the Administrator to receive an Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(u)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Performance Goals</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any objective or subjective goals the Administrator establishes with respect to an Award.  Performance Goals may include, but are not limited to, the performance of the Company or any one or more of its Subsidiaries, Affiliates or other business units with respect to the following measures&#58; net sales&#59; cost of sales&#59; gross income&#59; gross revenue&#59; revenue&#59; operating income&#59; earnings before taxes&#59; earnings before interest and taxes&#59; earnings before interest, taxes, depreciation and amortization&#59; earnings before interest, taxes, depreciation, amortization and exception items&#59; income from continuing operations&#59; net income&#59; earnings per share&#59; diluted earnings per share&#59; total stockholder return&#59; Fair Market Value&#59; cash flow&#59; net cash provided by operating activities&#59; net cash provided by operating activities less net cash used in investing activities&#59; ratio of debt to debt plus equity&#59; return on stockholder equity&#59; return on invested capital&#59; return on average total capital employed&#59; return on net capital employed&#59; return on assets&#59; return on net assets employed before interest and taxes&#59; operating working capital&#59; average accounts receivable (calculated by taking the average of accounts receivable at the end of each month)&#59; average inventories (calculated by taking the average of inventories at the end of each month)&#59; economic value added&#59; succession planning&#59; manufacturing return on assets&#59; manufacturing margin&#59; and customer satisfaction.  Performance Goals may also relate to a Participant&#8217;s individual performance.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Administrator reserves the right to adjust Performance Goals, or modify the manner of measuring or evaluating a Performance Goal, for any reason the Administrator determines is appropriate, including but not limited to&#58; (i) by excluding the effects of charges for reorganizing and restructuring&#59; discontinued operations&#59; asset write-downs&#59; gains or losses on the disposition of a business&#59; or mergers, acquisitions or dispositions&#59; and extraordinary, unusual and&#47;or non-recurring items of gain or loss&#59; (ii) excluding the costs of litigation, claims, judgments or settlements&#59; (iii) excluding the effects of changes laws or regulations affecting reported results, or changes in tax or accounting principles, regulations or law&#59; and (iv) excluding any accruals of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">amounts related to payments under the Plan or any other compensation arrangement maintained by the Company or an Affiliate.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(w)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">The inclusion in an Award agreement of specific adjustments or modifications shall not be deemed to preclude the Administrator from making other adjustments or modifications, in its discretion, as described herein, unless the Award agreement provides that the adjustments or modifications described in such agreement shall be the sole adjustments or modifications.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Performance Stock Unit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the right to receive a Share or a cash payment the value of which is equal to the Fair Market Value of one Share to the extent Performance Goals are achieved.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(y)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; has the meaning given in Section 3(a)(9) of the Exchange Act, as modified and used in Sections 13(d) and 14(d) thereof, or any group of Persons acting in concert that would be considered &#8220;persons acting as a group&#8221; within the meaning of Treas. Reg. &#167; 1.409A-3(i)(5).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(z)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means this PetMed Express, Inc. 2024 Omnibus Incentive Plan, as it may be amended from time to time. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Prior Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the PetMed Express, Inc. 2015 Outside Director Equity Compensation Plan and the PetMed Express, Inc. 2022 Employee Equity Compensation Plan.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ab)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Shares that are subject to a risk of forfeiture or restrictions on transfer, or both a risk of forfeiture and restrictions on transfer, which may lapse upon the achievement or partial achievement of Performance Goals or upon the completion of a period of service, or both. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ac)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.07pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Restricted Stock Unit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the right to receive a Share or a cash payment the value of which is equal to the Fair Market Value of one Share.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ad)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section&#160;16 Participants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means Participants who are subject to the provisions of Section&#160;16 of the Exchange Act. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ae)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Share</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a share of Stock. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(af)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.52pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the common stock of the Company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ag)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SAR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the right to receive a cash payment, and&#47;or Shares with a Fair Market Value, equal to the appreciation of the Fair Market Value of a Share during a specified period of time. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ah)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any corporation, limited liability company or other limited liability entity in an unbroken chain of entities beginning with the Company if each of the entities (other than the last entities in the chain) owns the stock or equity interest possessing more than fifty percent (50%) of the total combined voting power of all classes of stock or other equity interests in one of the other entities in the chain.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Administration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Administration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition to the authority specifically granted to the Administrator in this Plan, the Administrator has full discretionary authority to administer this Plan, including but not limited to the authority to&#58; (i)&#160;interpret the provisions of this Plan or any agreement covering an Award&#59; (ii)&#160;prescribe, amend and rescind rules and regulations relating to this Plan&#59; (iii)&#160;correct any defect, supply any omission, or reconcile any inconsistency in the Plan, any Award or any agreement covering an Award in the manner and to the extent it deems desirable to carry this Plan or such Award into effect&#59; and (iv)&#160;make all other determinations necessary or advisable for the administration of this Plan. All Administrator determinations shall be made in the sole discretion of the Administrator and are final and binding on all interested parties. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Delegation to Other Committees or Officers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent applicable law permits, the Board may delegate to another committee of the Board, or the Committee may delegate to a subcommittee of the Committee or to one or more officers of the Company, any or all of their respective authority and responsibility as an Administrator of the Plan&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> no such delegation is permitted with respect to Stock-based Awards made to Section&#160;16 Participants at the time any such delegated authority or responsibility is exercised unless the delegation is to another committee of the Board consisting entirely of Non-Employee Directors. If the Board or the Committee has made such a delegation, then all references to the Administrator in this Plan include such other committee, subcommittee or one or more officers to the extent of such delegation. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">No Liability&#59; Indemnification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No member of the Board or the Committee, and no officer or member of any other committee to whom a delegation under Section 3(b) has been made, will be liable for any act done, or determination made, by the individual in good faith with respect to the Plan or any Award. The Company will indemnify and hold harmless each such individual as to any acts or omissions, or determinations made, in each case done or made in good faith, with respect to this Plan or any Award to the maximum extent that the law and the Company&#8217;s By-Laws permit. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Administrator may designate any of the following as a Participant from time to time, to the extent of the Administrator&#8217;s authority&#58; any officer or other employee of the Company or its Affiliates&#59; any individual that the Company or an Affiliate has engaged to become an officer or employee&#59; any consultant or advisor who provides services to the Company or its Affiliates&#59; or any Director, including a Non-Employee Director. The Administrator&#8217;s designation of, or granting of an Award to, a Participant will not require the Administrator to designate such individual as a Participant or grant an Award to such individual at any future time. The Administrator&#8217;s granting of a particular type of Award to a Participant will not require the Administrator to grant any other type of Award to such individual.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Types of Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this Plan, the Administrator may grant any type of Award to any Participant it selects, but only employees of the Company or a Subsidiary may receive grants of incentive stock options within the meaning of Code Section 422. Awards may be granted alone or in addition to, in tandem with, or (subject to the prohibition on repricing set forth in Section&#160;15(e)) in substitution for any other Award (or any other award granted under another plan of the Company or any Affiliate, including the plan of an acquired entity).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Shares Reserved under this Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Plan Reserve</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to adjustment as provided in Section 17, an aggregate of Eight Hundred Fifty Thousand (850,000) plus the number of Shares available for issuance under the Prior Plans that have not, as of the Effective Date, been made subject to outstanding awards, plus the number of Shares described Section 6(d) below, are reserved for issuance under this Plan.  The Shares reserved for issuance may be either authorized and unissued Shares or Shares reacquired at any time and now or hereafter held as treasury stock. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Depletion of Shares Under this Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The aggregate number of Shares reserved under Section 6(a) shall be depleted on the date of grant of an Award by the maximum number of Shares, if any, with respect to which such Award is granted.  The reserve shall also be depleted by any Shares issued in settlement of a Dividend Equivalent.  For clarity, an Award that may be settled solely in cash shall not cause any depletion of the Plan&#8217;s Share reserve at the time such Award is granted.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">Replenishment of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">If (A) an Award lapses, expires, terminates or is cancelled without the issuance of Shares under the Award (whether due currently or on a deferred basis) or is settled in cash, (B)&#160;it is determined during or at the conclusion of the term of an Award that all or some portion of the Shares with respect to which the Award was granted will not be issuable on the basis that the conditions for such issuance will not be satisfied, (C) Shares are forfeited under an Award, or (D) Shares are issued under any Award and the Company subsequently reacquires them pursuant to rights reserved upon the issuance of the Shares (such as the right to repurchase Restricted Stock at the amount paid by the Participant), then such Shares shall be recredited to the Plan&#8217;s reserve and may again be used for new Awards under the Plan, provided that the Shares recredited to the Plan&#8217;s reserve pursuant to clause (D) may not be issued pursuant to incentive stock options.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">For clarity, the following Shares will not be recredited to the Plan&#8217;s reserve&#58; (A) Shares tendered or withheld in payment of the exercise price of an Option or as a result of the net settlement of an outstanding Stock Appreciation Right&#59; (B) Shares tendered or withheld to satisfy federal, state or local tax withholding obligations&#59; and (C) Shares purchased by the Company using proceeds from Option exercises.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Addition of Shares from Prior Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  After the Effective Date, if any Shares subject to awards granted under the Prior Plans, or granted under the PetMed Express, Inc. 2016 Employee Equity Compensation Restricted Stock Plan, would again become available for new grants under Section 6(c) of this Plan if such award had been granted under this Plan, then those Shares will be added to the Plan reserve described in Section 6(a) and will be available for the purpose of granting Awards under this Plan. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Non-Employee Director Award Limitation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In no event shall the aggregate grant date value (determined in accordance with generally accepted accounting principles) of all Awards granted to any individual Non-Employee Director during a fiscal year of the Company, when added to any cash compensation received by such Non-Employee Director in the same fiscal year, exceed $750,000.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.63pt">Incentive Stock Option Limit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Subject to adjustment as provided in Section 17, the Company may issue an aggregate of Eight Hundred Fifty Thousand (850,000) Shares upon the exercise of Incentive Share Options.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Options</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this Plan, the Administrator will determine all terms and conditions of each Option, including but not limited to&#58; (a) whether the Option is an &#8220;incentive stock option&#8221; which meets the requirements of Code Section&#160;422, or a &#8220;nonqualified stock option&#8221; which does not meet the requirements of Code Section&#160;422&#59; (b) the grant date, which may not be any day prior to the date that the Administrator approves the grant&#59; (c) the number of Shares subject to the Option&#59; (d) the exercise price, which may never be less than the Fair Market Value of the Shares subject to the Option as determined on the date of grant&#59; (e) the terms and conditions of vesting and exercise&#59; (f) the term, except that an Option must terminate no later than ten (10)&#160;years after the date of grant&#59; and (g) the manner of payment of the exercise price. In all other respects, the terms of any incentive stock option should comply with the provisions of Code Section&#160;422 except to the extent the Administrator determines otherwise.  If an Option that is intended to be an incentive stock option fails to meet the requirements thereof, the Option shall automatically be treated as a nonqualified stock option to the extent of such failure. To the extent previously approved by the Administrator (which approval may be set forth in an Award agreement or in administrative rules), and subject to such procedures as the Administrator may specify, the payment of the exercise price of Options may be made by (i) delivery of cash or other Shares or other securities of the Company (including by attestation) having a then Fair Market Value equal to the purchase price of such Shares, (ii) by delivery (including by fax) to the Company or its designated agent of an executed irrevocable option exercise form together with irrevocable instructions to a broker-dealer to sell or margin a sufficient portion of the Shares and deliver the sale or margin loan proceeds directly to the Company to pay for the exercise price, (iii) by surrendering the right to receive Shares otherwise deliverable to the Participant upon exercise of the Award having a Fair Market Value at the time of exercise equal to the total exercise price, or (iv) by any combination of (i), (ii) and&#47;or (iii). Except to the extent otherwise set forth in an Award agreement, a Participant shall have no rights as a holder of Stock as a result of the grant of an Option until the Option is exercised, the exercise price and applicable withholding taxes are paid and the Shares subject to the Option are issued thereunder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Stock Appreciation Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this Plan, the Administrator will determine all terms and conditions of each SAR, including but not limited to&#58; (a) the grant date, which may not be any day prior to the date that the Administrator approves the grant&#59; (b) the number of Shares to which the SAR relates&#59; (c) the grant price, which may never be less than the Fair Market Value of the Shares subject to the SAR as determined on the date of grant&#59; (d) the terms and conditions of exercise or maturity, including vesting&#59; (e) the term, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> an SAR  must terminate no later than ten (10) years after the date of grant&#59; and (f) whether the SAR will be settled in cash, Shares or a combination thereof. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.84pt;text-decoration:underline">Stock, Restricted Stock and Stock Unit Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this Plan, the Administrator will determine all terms and conditions of each award of Shares, Restricted Stock, Restricted Stock Units, or Performance Stock Units, including but not limited to&#58; (a) the number of Shares and&#47;or units granted under the Award&#59; (b) whether, as a condition for the Participant to realize all or a portion of the benefit provided under the Award, one or more Performance Goals must be achieved during such period as the Administrator specifies&#59; (c)&#160;the length of the vesting and&#47;or performance period and, if different, the date on which payment of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the benefit provided under the Award will be made&#59; and (d) with respect to Restricted Stock Units and Performance Stock Units, whether to settle such Awards in cash, in Shares (including Restricted Stock), or in a combination of cash and Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Cash Incentive Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this Plan, the Administrator will determine all terms and conditions of a Cash Incentive Award, including but not limited to the Performance Goals, performance period, the potential amount payable, and the timing of payment.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Other Stock-Based Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Subject to the terms of this Plan, the Administrator may grant to a Participant shares of unrestricted Stock as replacement for other compensation to which the Participant is entitled, such as in payment of director fees, in lieu of cash compensation, in exchange for cancellation of a compensation right, or as a bonus.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Dividends and Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Prohibitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  In no event may dividends or Dividend Equivalents be awarded with respect to Options, SARs or any other stock-based award that is not a grant of Restricted Stock, Restricted Stock Units or Performance Stock Units.  Notwithstanding anything to the contrary in this Plan, and for the avoidance of doubt, this Plan expressly prohibits the payment of dividends or Dividend Equivalents on unvested Awards for all equity Award types, provided that Section 12(b) and 12(c) shall apply to Awards when and if they become vested.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Dividends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If cash dividends are paid on the Stock while shares of Restricted Stock are unvested, then such dividends will either, at the discretion of the Administrator, be (i) automatically reinvested as additional shares of Restricted Stock that are subject to the same terms and conditions, including the risk of forfeiture, as the original grant of Restricted Stock, or (ii) paid in cash at the same time and the same extent that the Restricted Stock vests.  For clarity, in no event will dividends be distributed to a Participant unless, until and to the same extent as the underlying Restricted Stock vests.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">Dividend Equivalents.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">An award of Restricted Stock Units or Performance Stock Units may include the right to receive Dividend Equivalents.  Dividend Equivalents will either, at the discretion of the Administrator, be (i) accumulated and paid, in cash or Shares in the Administrator&#8217;s discretion, at the same time and to the same extent that the tandem Award vests or is earned or (ii) reinvested in additional units that are subject to the same terms and conditions (including vesting and forfeiture) as the tandem Award.  For clarity, in no event will a Participant receive payment of Dividend Equivalents unless, until and to the same extent as the tandem Award vests and is paid.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Minimum Vesting Period&#59; Discretion to Accelerate Vesting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Minimum Vesting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  All Awards granted under the Plan shall have a minimum vesting period of one year from the date of grant, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such minimum vesting period will not apply to Awards with respect to up to 5% in the aggregate of the total number of Shares reserved pursuant to Section 6(a).  For purposes of Awards granted to Non-Employee Directors, &#8220;one year&#8221; may mean the period of time from one annual shareholders meeting to the next annual shareholders meeting, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> that such period of time is not less than 50 weeks.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Discretion to Accelerate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding Section 13(a), the Administrator may accelerate the vesting of an Award or deem an Award to be earned, in whole or in part, in the event of a Participant&#8217;s death, Disability, retirement, or termination without Cause, or as provided in Section 18 or upon any other event as determined by the Administrator in its sole and absolute discretion.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  Awards are not transferable, including to any financial institution, other than by will or the laws of descent and distribution, unless and to the extent the Administrator allows a Participant to&#58; (a) designate in writing a beneficiary to exercise the Award or receive payment under the Award after the Participant&#8217;s death&#59; (b) transfer an Award to the former spouse of the Participant as required by a domestic relations order incident to a divorce&#59; or (c) transfer an Award&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, that with respect to clause (c) above the Participant may not receive consideration for such a transfer of an Award.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Termination and Amendment of Plan&#59; Amendment, Modification or Cancellation of Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Term of Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Unless the Board earlier terminates this Plan pursuant to Section 15(b), this Plan will terminate on, and no further Awards may be granted under this Plan, after the tenth (10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the Effective Date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Termination and Amendment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Board or the Administrator may amend, alter, suspend, discontinue or terminate this Plan at any time, subject to the following limitations&#58; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">the Board must approve any amendment of this Plan to the extent the Company determines such approval is required by&#58; (A)&#160;prior action of the Board, (B)&#160;applicable corporate law, or (C) any other applicable law&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">stockholders must approve any amendment of this Plan (which may include an amendment to materially increase the number of Shares specified in Section 6(a), except as permitted by Section 17) to the extent the Company determines such approval is required by&#58; (A)&#160;Section&#160;16 of the Exchange Act, (B)&#160;the Code, (C)&#160;the listing requirements of any principal securities exchange or market on which the Shares are then traded, or (D) any other applicable law&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">stockholders must approve an amendment that would diminish the protections afforded by Section&#160;15(e).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">If the Board or the Administrator takes any action under this Plan that is not, at the time of such action, authorized by this Plan, but that could be authorized by this Plan as amended by the Board or the Administrator, as applicable, the Board or Administrator action will be deemed to constitute an amendment to this Plan to authorize such action to the extent permissible under applicable law and the requirements of any principal securities exchange or market on which the Shares are then traded. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">Amendment, Modification, Cancellation and Disgorgement of Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">Except as provided in Section&#160;15(e) and subject to the requirements of this Plan, the Administrator may modify, amend or cancel any Award, or waive any restrictions or conditions applicable to any Award or the exercise of the Award&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, except as otherwise provided in the Plan or the Award agreement, any modification or amendment that materially diminishes the rights of the Participant, or the cancellation of an Award, shall be effective only if agreed to by the Participant or any other person(s) as may then have an interest in such Award, but the Administrator need not obtain Participant (or other interested party) consent for the modification, amendment or cancellation of an Award pursuant to the provisions of subsection (ii) or Section&#160;17 or as follows&#58; (A) to the extent the Administrator deems such action necessary to comply with any applicable law or the listing requirements of any principal securities exchange or market on which the Shares are then traded&#59; (B) to the extent the Administrator deems necessary to preserve favorable accounting or tax treatment of any Award for the Company&#59; or (C) to the extent the Administrator determines that such action does not materially and adversely affect the value of an Award or that such action is in the best interest of the affected Participant (or any other person(s) as may then have an interest in the Award). Notwithstanding the foregoing, unless determined otherwise by the Administrator, any such amendment shall be made in a manner that will enable an Award intended to be exempt from Code Section 409A to continue to be so exempt, or to enable an Award intended to comply with Code Section 409A to continue to so comply. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding anything to the contrary in an Award agreement, the Administrator shall have full power and authority to terminate or cause the Participant to forfeit the Award, and require the Participant to disgorge to the Company any gains attributable to the Award, if the Participant engages in any action constituting, as determined by the Administrator in its discretion, Cause for termination, or a breach of a material Company policy, any Award agreement or any other agreement between the Participant and the Company or an Affiliate concerning noncompetition, nonsolicitation, confidentiality, trade secrets, intellectual property, nondisparagement or similar obligations. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">Any Awards granted pursuant to this Plan, and any Stock issued or cash paid pursuant to an Award, shall be subject to any recoupment or clawback policy that is adopted by, or any recoupment or similar requirement otherwise made applicable by law, regulation or listing standards to, the Company from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Survival of Authority and Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, the authority of the Board and the Administrator under this Section 15 and to otherwise administer the Plan with respect to then-outstanding Awards will extend beyond the date of this Plan&#8217;s termination. In addition, termination of this Plan will not affect the rights of Participants with respect to Awards previously granted to them, and all unexpired Awards will continue in force and effect after termination of this Plan except as they may lapse or be terminated by their own terms and conditions. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Repricing and Backdating Prohibited</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Plan to the contrary, and except for the adjustments provided for in Section&#160;17, neither the Administrator nor any other person may (i) amend the terms of outstanding Options or SARs to reduce the exercise or grant price of such outstanding Options or SARs&#59; (ii) cancel outstanding Options or SARs in exchange for Options or SARs with an exercise or grant price that is less than the exercise or grant price of the original Options or SARs&#59; or (iii) cancel outstanding Options or SARs with an exercise or grant price above the current Fair Market Value of a Share in exchange for cash or other securities. In addition, the Administrator may not make a grant of an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Option or SAR with a grant date that is effective prior to the date the Administrator takes action to approve such Award. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.63pt">Foreign Participation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To assure the viability of Awards granted to Participants employed or residing in foreign countries, the Administrator may provide for such special terms as it may consider necessary or appropriate to accommodate differences in local law, tax policy, accounting or custom. Moreover, the Administrator may approve such supplements to, or amendments, restatements or alternative versions of, this Plan as it determines is necessary or appropriate for such purposes. Any such amendment, restatement or alternative versions that the Administrator approves for purposes of using this Plan in a foreign country will not affect the terms of this Plan for any other country. In addition, all such supplements, amendments, restatements or alternative versions must comply with the provisions of Section&#160;15(b)(ii). </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Withholding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In the event the Company or one of its Affiliates is required to withhold any Federal, state or local taxes or other amounts in respect of any income recognized by a Participant as a result of the grant, vesting, payment or settlement of an Award or disposition of any Shares acquired under an Award, the Company may satisfy such obligation by&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">If cash is payable under an Award, deducting (or requiring an Affiliate to deduct) from such cash payment the amount needed to satisfy such obligation&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">If Shares are issuable under an Award, then to the extent previously approved by the Administrator (which approval may be set forth in an Award agreement or in administrative rules), and subject to such procedures as the Administrator may specify, (A) withholding Shares having a Fair Market Value equal to such obligations&#59; or (B) allowing the Participant to elect to (1)&#160;have the Company or its Affiliate withhold Shares otherwise issuable under the Award, (2)&#160;tender back Shares received in connection with such Award or (3)&#160;deliver other previously owned Shares, in each case having a Fair Market Value equal to the amount to be withheld&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the amount to be withheld under this clause (ii) may not exceed the total maximum statutory tax withholding obligations associated with the transaction to the extent needed for the Company and its Affiliates to avoid an accounting charge. If an election is provided, the election must be made on or before the date as of which the amount of tax to be withheld is determined and otherwise as the Administrator requires&#59; or</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">Deducting (or requiring an Affiliate to deduct) the amount needed to satisfy such obligation from any wages or other payments owed to the Participant, requiring such Participant to pay to the Company or its Affiliate, in cash, promptly on demand, or make other arrangements satisfactory to the Company or its Affiliate regarding the payment to the Company or its Affiliate of the amount needed to satisfy such obligation.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">No Guarantee of Tax Treatment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any provisions of this Plan to the contrary, the Company does not guarantee to any Participant or any other Person with an interest in an Award that (i) any Award intended to be exempt from Code Section 409A shall be so exempt, (ii) any Award intended to comply with Code Section 409A or Code Section 422 shall </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">so comply, or (iii) any Award shall otherwise receive a specific tax treatment under any other applicable tax law, nor in any such case will the Company or any Affiliate be required to indemnify, defend or hold harmless any individual with respect to the tax consequences of any Award. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Adjustment and Change of Control Provisions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Adjustment of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If (i) the Company shall at any time be involved in a merger or other transaction in which the Shares are changed or exchanged&#59; (ii) the Company shall subdivide or combine the Shares or the Company shall declare a dividend payable in Shares, other securities (other than stock purchase rights issued pursuant to a stockholder rights agreement) or other property&#59; (iii) the Company shall effect a cash dividend the amount of which, on a per Share basis, exceeds ten percent (10%) of the Fair Market Value of a Share at the time the dividend is declared, or the Company shall effect any other dividend or other distribution on the Shares in the form of cash, or a repurchase of Shares, that the Board determines by resolution is special or extraordinary in nature or that is in connection with a transaction that the Company characterizes publicly as a recapitalization or reorganization involving the Shares&#59; or (iv) any other event shall occur, which, in the case of this clause (iv), in the judgment of the Administrator necessitates an adjustment to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this Plan, then the Administrator shall, in such manner as it may deem equitable to prevent dilution or enlargement of the benefits or potential benefits intended to be made available under this Plan, adjust any or all of&#58; (A)&#160;the number and type of Shares subject to this Plan (including the number and type of Shares described in Section 6(a)) and which may after the event be made the subject of Awards&#59; (B)&#160;the number and type of Shares subject to outstanding Awards&#59; (C)&#160;the grant, purchase, or exercise price with respect to any Award&#59; and (D) the Performance Goals of an Award. In any such case, the Administrator may also (or in lieu of the foregoing) make provision for a cash payment to the holder of an outstanding Award in exchange for the cancellation of all or a portion of the Award (without the consent of the holder of an Award) in an amount determined by the Administrator effective at such time as the Administrator specifies (which may be the time such transaction or event is effective). However, in each case, with respect to Awards of incentive stock options, no such adjustment may be authorized to the extent that such authority would cause this Plan to violate Code Section&#160;422(b). Further, the number of Shares subject to any Award payable or denominated in Shares must always be a whole number. In any event, previously granted Options or SARs are subject to only such adjustments as are necessary to maintain the relative proportionate interest the Options and SARs represented immediately prior to any such event and to preserve, without exceeding, the value of such Options or SARs.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Without limitation, in the event of any reorganization, merger, consolidation, combination or other similar corporate transaction or event, whether or not constituting a Change of Control (other than any such transaction in which the Company is the continuing corporation and in which the outstanding Stock is not being converted into or exchanged for different securities, cash or other property, or any combination thereof), the Administrator may substitute, on an equitable basis as the Administrator determines, for each Share then subject to an Award and the Shares subject to this Plan (if the Plan will continue in effect), the number and kind of shares of stock, other securities, cash or other property to which holders of Stock are or will be entitled in respect of each Share pursuant to the transaction. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, in the case of a stock dividend (other than a stock dividend declared in lieu of an ordinary cash dividend) or subdivision or combination of the Shares (including a reverse stock split), if no action is taken by the Administrator, adjustments contemplated by this subsection that are proportionate shall nevertheless automatically be made as of the date of such stock dividend or subdivision or combination of the Shares.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Issuance or Assumption</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of this Plan, and without affecting the number of Shares otherwise reserved or available under this Plan, in connection with any merger, consolidation, acquisition of property or stock, or reorganization, the Administrator may authorize the issuance or assumption of awards under this Plan upon such terms and conditions as it may deem appropriate. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Effect of Change of Control.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">Upon a Change of Control, except to the extent otherwise provided in an applicable Award agreement or by the Administrator prior to the date of the Change of Control, if the successor or surviving corporation (or parent thereof) so agrees, then, without the consent of any Participant (or other person with rights in an Award), some or all outstanding Awards may be assumed, or replaced with the same type of award with similar terms and conditions, by the successor or surviving corporation (or parent thereof) in the Change of Control transaction, subject to the following requirements&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">Each Award which is assumed by the successor or surviving corporation (or parent thereof) shall be appropriately adjusted, immediately after such Change of Control, to apply to the number and class of securities which would have been issuable to the Participant upon the consummation of such Change of Control had the Award been exercised, vested or earned immediately prior to such Change of Control, and such other appropriate adjustments in the terms and conditions of the Award shall be made.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">If the securities to which the Awards relate after the Change of Control are not listed and traded on a national securities exchange, then (1) the Participant shall be provided the option, upon exercise or settlement of an Award, to elect to receive, in lieu of the issuance of such securities, cash in an amount equal to the fair value equal of the securities that would have otherwise been issued and (2) for purposes of determining such fair value, no reduction shall be taken to reflect a discount for lack of marketability, minority interest or any similar consideration.   </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">Upon the Participant&#8217;s termination of employment within one year following the Change of Control (1) by the successor or surviving corporation without Cause, (2) by reason of death or Disability, or (3) by the Participant for &#8220;good reason,&#8221; as defined in any Award agreement or any employment, retention, change of control, severance or similar agreement between the Participant and the Company or any Affiliate, if any, all of the Participant&#8217;s Awards that are in effect as of the date of such termination shall vest in full or be deemed earned in full (assuming target performance goals provided under such Award were met, if applicable) effective on the date of such termination.  In the event of any other termination of employment within one year after a Change of Control that is not described herein, the terms of the Award agreement shall apply.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.57pt">To the extent the purchaser, successor or surviving entity (or parent thereof) in the Change of Control transaction does not assume the Awards or issue replacement awards as provided in clause (i) (including, for the avoidance of doubt, by reason of a Participant&#8217;s termination of employment upon the occurrence of the Change of Control), then immediately prior to the date of the Change of Control, except to the extent otherwise provided in an applicable Award agreement and unless the Administrator otherwise determines prior to the Change of Control&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">Each Award that is then held by a Participant who is employed by or in the service of the Company or an Affiliate immediately prior to the Change of Control shall become immediately and fully vested assuming, with respect to Awards subject to Performance Goals for which the performance period has not expired as of the Change of Control, that all Performance Goals were met at target.  For the avoidance of doubt, if the performance period of an Award had expired prior to the Change of Control, then such Awards will vest based on the actual level of performance achieved during the performance period.  In addition, if the Company enters into an agreement or series of agreements or the Board adopts a resolution that results in the occurrence a Change of Control at a later date, and the employment of a Participant is terminated after and as the sole result of the entering into of such agreement or series of agreements or the adoption of such resolution but prior to the Change of Control, then, to the extent reasonably practicable, such Participant whose employment was so terminated shall be treated as though the Participant was employed immediately prior to the Change of Control for purposes of this subsection (b) and any Awards previously forfeited as a result of such termination of employment shall be reinstated or, if so determined by the Company, the Participant shall instead be eligible to receive a cash payment approximating the value of such Awards.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">All vested Awards shall be settled or paid in accordance with the terms of the Award agreement (including payment of any accrued dividends and Dividend Equivalents), in all cases as of immediately prior to the occurrence of the Change of Control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">Notwithstanding (ii), the Company may cancel all vested Awards on the date of the Change of Control in exchange for a cash payment.  With respect to Options and SARs, the cash payment shall equal to the excess of the Change of Control Price (as defined below) of the Shares covered by the Option or SAR that is so cancelled over the purchase or grant price of such Shares under the Award, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided, however, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">that all Options and SARs that have a purchase or grant price that is greater than the Change of Control Price shall be cancelled for no consideration.  With respect to Restricted Stock, Restricted Stock Units, and Performance Stock Units, the cash payment shall equal the Change of Control Price multiplied by the number of vested shares or units, as applicable, plus the amount of any accrued by unpaid cash dividends or Dividend Equivalents, if any.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;Change of Control Price&#8221; shall mean the per share price paid or deemed paid in the Change of Control transaction, as determined by the Administrator.  For purposes of this clause (iii), if the value of an Award is based on the Fair Market Value of a Share, Fair Market Value shall be deemed to mean the Change of Control Price.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">Application of Limits on Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Except to the extent the Participant has in effect an employment or similar agreement with the Company or any Affiliate or is subject to a policy that provides for a more favorable result to the Participant upon a Change of Control, in the event that the Company&#8217;s legal counsel determine that any payment, benefit or transfer by the Company under this Plan or any other plan, agreement, or arrangement to or for the benefit of the Participant (in the aggregate, the &#8220;Total Payments&#8221;) to be subject to the tax (&#8220;Excise Tax&#8221;) imposed by Code Section 4999 but for this subsection (c), then, notwithstanding any other provision of this Plan to the contrary, the Total Payments shall be delivered either (i) in full or (ii) in an amount such that the value of the aggregate Total Payments that the Participant is entitled to receive shall be One Dollar ($1.00) less than the maximum amount that the Participant may receive without being subject to the Excise Tax, whichever of (i) or (ii) results in the receipt by the Participant of the greatest benefit on an after-tax basis (taking into account applicable federal, state and local income taxes and the Excise Tax).  In the event that (ii) results in a greater after-tax benefit to the Participants, payments or benefits included in the Total Payments shall be reduced or eliminated by applying the following principles, in order&#58; (A) the payment or benefit with the higher ratio of the parachute payment value to present economic value (determined using reasonable actuarial assumptions) shall be reduced or eliminated before a payment or benefit with a lower ratio&#59; (B) the payment or benefit with the later possible payment date shall be reduced or eliminated before a payment or benefit with an earlier payment date&#59; and (C) cash payments shall be reduced prior to non-cash benefits&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> if the foregoing order of reduction or elimination would violate Code Section 409A, then the reduction shall be made pro rata among the payments or benefits included in the Total Payments (on the basis of the relative present value of the parachute payments). </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:20.73pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Other Terms and Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Administrator may provide in any Award agreement such other provisions (whether or not applicable to the Award granted to any other Participant) as the Administrator determines appropriate to the extent not otherwise prohibited by the terms of the Plan.  No provision in an Award agreement shall limit the Administrator&#8217;s discretion hereunder unless such provision specifically so provides for such limitation.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Employment and Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The issuance of an Award shall not confer upon a Participant any right with respect to continued employment or service with the Company or any Affiliate, or the right to continue as a Director. Unless determined otherwise by the Administrator, for purposes of the Plan and all Awards, the following rules shall apply&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:26.24pt">a Participant who transfers employment between the Company and its Affiliates, or between Affiliates, will not be considered to have terminated employment&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">a Participant who ceases to be a Non-Employee Director because he or she becomes an employee of the Company or an Affiliate shall not be considered to have ceased service as a Director with respect to any Award until such Participant&#8217;s termination of employment with the Company and its Affiliates&#59;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.36pt">a Participant who ceases to be employed by the Company or an Affiliate and immediately thereafter becomes a Non-Employee Director, a non-employee director of an Affiliate, or a consultant to the Company or any Affiliate shall not be considered to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">have terminated employment until such Participant&#8217;s service as a director of, or consultant to, the Company and its Affiliates has ceased&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.74pt">a Participant employed by an Affiliate will be considered to have terminated employment when such entity ceases to be an Affiliate. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, for purposes of an Award that is subject to Code Section 409A, if a Participant&#8217;s termination of employment or service triggers the payment of compensation under such Award, then the Participant will be deemed to have terminated employment or service upon his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A. Notwithstanding any other provision in this Plan or an Award to the contrary, if any Participant is a &#8220;specified employee&#8221; within the meaning of Code Section 409A as of the date of his or her &#8220;separation from service&#8221; within the meaning of Code Section 409A, then, to the extent required to avoid the imposition of additional taxes under Code Section 409A, any payment made to the Participant on account of such separation from service shall not be made before a date that is six months after the date of the separation from service.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:23.18pt">No Fractional Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. No fractional Shares or other securities may be issued or delivered pursuant to this Plan, and the Administrator may determine whether cash, other securities or other property will be paid or transferred in lieu of any fractional Shares or other securities, or whether such fractional Shares or other securities or any rights to fractional Shares or other securities will be canceled, terminated or otherwise eliminated with or without consideration.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Unfunded Plan&#59; Awards Not Includable for Benefits Purposes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Plan is unfunded and does not create, and should not be construed to create, a trust or separate fund with respect to this Plan&#8217;s benefits. This Plan does not establish any fiduciary relationship between the Company and any Participant or other person. To the extent any person holds any rights by virtue of an Award granted under this Plan, such rights are no greater than the rights of the Company&#8217;s general unsecured creditors. Income recognized by a Participant pursuant to an Award shall not be included in the determination of benefits under any employee pension benefit plan (as such term is defined in Section 3(2) of the Employee Retirement Income Security Act of 1974, as amended) or group insurance or other benefit plans applicable to the Participant which are maintained by the Company or any Affiliate, except as may be provided under the terms of such plans or determined by resolution of the Board.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Requirements of Law and Securities Exchange</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The granting of Awards and the issuance of Shares in connection with an Award are subject to all applicable laws, rules and regulations and to such approvals by any governmental agencies or national securities exchanges as may be required. Notwithstanding any other provision of this Plan or any award agreement, the Company has no liability to deliver any Shares under this Plan or make any payment unless such delivery or payment would comply with all applicable laws and the applicable requirements of any securities exchange or similar entity, and unless and until the Participant has taken all actions required by the Company in connection therewith. The Company may impose such restrictions on any Shares issued under the Plan as the Company determines necessary or desirable to comply with all applicable laws, rules and regulations or the requirements of any national securities exchanges. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:25.63pt">Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Any Award granted under this Plan shall be provided or made in such manner and at such time as to either make the Award exempt from, or comply with, the provisions of Code Section 409A, to avoid a plan failure described in Code Section 409(a)(1), and the provisions of Code Section 409A are incorporated into this Plan to the extent necessary for any Award that is subject to Code Section 409A to comply therewith.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Governing Law&#59; Venue.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> This Plan, and all agreements under this Plan, will be construed in accordance with and governed by the laws of the State of Florida, without reference to any conflict of law principles. Any legal action or proceeding with respect to this Plan, any Award or any award agreement, or for recognition and enforcement of any judgment in respect of this Plan, any Award or any award agreement, may only be brought and determined in (i) a court sitting in the State of Florida, and (ii) a &#8220;bench&#8221; trial, and any party to such action or proceeding shall agree to waive its right to a jury trial.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.57pt">Limitations on Actions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Any legal action or proceeding with respect to this Plan, any Award or any award agreement, must be brought within one year (365 days) after the day the complaining party first knew or should have known of the events giving rise to the complaint. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.24pt">Construction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Whenever any words are used herein in the masculine, they shall be construed as though they were used in the feminine in all cases where they would so apply&#59; and wherever any words are used in the singular or plural, they shall be construed as though they were used in the plural or singular, as the case may be, in all cases where they would so apply. Titles of sections are for general information only, and this Plan is not to be construed with reference to such titles.  The title, label or characterization of an Award in an award agreement or in the Company&#8217;s public filings or other disclosures shall not be determinative as to which specific Award type is represented by the award agreement.  Instead, the Administrator may determine which specific type(s) of Award(s) is (are) represented by any award agreement, at the time such Award is granted or at any time thereafter.  Except to the extent otherwise provided in the applicable award agreement, in the case of any Award that includes a &#8220;series of installment payments&#8221; (within the meaning of Section 1.409A-2(b)(2)(iii) of the Treasury Regulations), the Award holder&#8217;s right to the series of installment payments shall be treated as a right to a series of separate payments and not as a right to a single payment.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:26.24pt">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any provision of this Plan or any award agreement or any Award (i)&#160;is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction, or as to any person or Award, or (ii)&#160;would cause this Plan, any award agreement or any Award to violate or be disqualified under any law the Administrator deems applicable, then such provision should be construed or deemed amended to conform to applicable laws, or if it cannot be so construed or deemed amended without, in the determination of the Administrator, materially altering the intent of this Plan, award agreement or Award, then such provision should be stricken as to such jurisdiction, person or Award, and the remainder of this Plan, such award agreement and such Award will remain in full force and effect. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1 1
<SEQUENCE>3
<FILENAME>exhibit1011formofrsuaward.htm
<DESCRIPTION>EX-10.1 1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i7959e0d47b6e4bb6a2ec20f7007496e0_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2024 OMNIBUS INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RESTRICTED STOCK UNIT AWARD</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;PARTICIPANTID&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;FIRSTNAME&#93; &#91;LASTNAME&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear &#91;NAME&#93;&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You have been granted an award of Restricted Stock Units (this &#8220;Award&#8221;) of PetMed Express, Inc. (the &#8220;Company&#8221;) under the PetMed Express, Inc. 2024 Omnibus Incentive Plan (the &#8220;Plan&#8221;), effective as of the Grant Date, with the terms and conditions set forth below.  Capitalized terms used in this Award and not defined shall have the meanings given in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grant Date&#58;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;GRANT DATE&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vesting Commencement Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;VESTING COMMENCEMENT DATE&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Number of Restricted Stock Units&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;NUMBER OF RSUs&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;____&#93; of the Restricted Stock Units will vest on each of the first &#91;___&#93; anniversaries of the Vesting Commencement Date, provided you are continuously employed by, or in service with, the Company or an Affiliate until the applicable vesting date.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If your employment or service with the Company and its Affiliates terminates (voluntarily or involuntarily) before the Restricted Stock Units are fully vested for any reason other than due to your death or Disability, all then-unvested Restricted Stock Units will be immediately and automatically forfeited on the date of such termination.  If your employment or service with the Company and its Affiliates terminates before the Restricted Stock Units are fully vested due to your death or Disability, the then-unvested Restricted Stock Units will immediately be deemed vested full.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the terms of Section 18 of the Plan, the Restricted Stock Units will not vest upon a Change of Control unless the Administrator, in connection with such Change of Control, expressly provides for the vesting of such Restricted Stock Units.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Settlement of Restricted Stock Units&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">As soon as practicable after your Restricted Stock Units vest (but no later than two-and-one-half months from the end of the fiscal year in which vesting occurs), the Company will settle such vested Restricted Stock Units by issuing in your name certificate(s) or making an appropriate book entry for a number of Shares equal to the number of Restricted Stock Units that have vested.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Transferability of </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restricted Stock Units&#58;</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You may not sell, transfer or otherwise alienate or hypothecate this Award or any of your Restricted Stock Units until they are vested. In addition, by accepting this Award, you agree not to sell any Shares acquired under this Award other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale. The Company also may require you to enter into a stockholder&#8217;s agreement that will include additional restrictions on the transfer of Shares acquired under this Award.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Rights as Stockholder&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You will not be deemed for any purposes to be a stockholder of the Company with respect to any of the Restricted Stock Units (including with respect to voting or dividends) unless and until a certificate for Shares is issued upon vesting of the Restricted Stock Units or the Company makes an appropriate book entry for a number of Shares equal to the number of Restricted Stock Units that have vested.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Market Stand-Off&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Award without the prior written consent of the Company.  Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company.  In no event, however, shall such period exceed one hundred eighty (180) days.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand that you (and not the Company or any Affiliate) shall be responsible for your own federal, state, local or foreign tax liability and any of your other tax consequences that may arise as a result of the transactions contemplated by this Award. You shall rely solely on the determinations of your tax advisors or your own determinations, and not on any statements or representations by the Company or any of its agents, with regard to all such tax matters.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent that the receipt, vesting or settlement of the Restricted Stock Units, or other event, results in income to you for federal, state or local income tax purposes, you shall deliver to the Company at the time the Company is obligated to withhold taxes in connection with such receipt, vesting, settlement or other event, as the case may be, such amount as the Company requires to meet its withholding obligation under applicable tax laws or regulations. If you fail to do so, the Company has the right and authority to deduct or withhold from other compensation payable to you an amount sufficient to satisfy its withholding obligations.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent permitted by the Company at the time a tax withholding requirement arises, you may satisfy the withholding requirement in whole or in part, by electing to have the Company withhold for its own account that number of Shares otherwise deliverable to you upon settlement having an aggregate Fair Market Value on the date the tax is to be determined equal to the tax that the Company must withhold in connection with the vesting or settlement of such Restricted Stock Units&#59; provided that the amount so withheld shall not exceed the maximum statutory rate to the extent necessary to avoid an accounting charge. Your election must be irrevocable, in writing, and submitted to the Secretary of the Company before the applicable vesting or settlement date. The Fair Market Value of any fractional Share not used to satisfy the withholding obligation (as determined on the date the tax is determined) will be paid to you in cash.</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Miscellaneous&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">Neither the Plan nor the grant of this Award shall constitute or be evidence of any agreement or understanding, express or implied, that you have a right to continue as an employee of the Company or any of its Affiliates for any period of time, or at any particular rate of compensation.</font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">The Plan and this Award constitute the entire understanding of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements between you and the Company with respect to the subject matter hereof.  You expressly warrant that you are not accepting this Award in reliance on any promises, representations, or inducements other than those contained herein.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">By accepting the grant of the Restricted Stock Units, you agree not to sell any Shares acquired in connection with the Restricted Stock Units other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale.  </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">As a condition of the granting of this Award, you agree, for yourself and your legal representatives or guardians, that this Award shall be interpreted by the Administrator and that any interpretation by the Administrator of the terms of this Award or the Plan and any determination made by the Administrator pursuant to this Award shall be final, binding and conclusive.  </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">Subject to the terms of the Plan, the Administrator may modify or amend this Award without your consent as permitted by Section 15(c) of the Plan or&#58; (i) to the extent such action is deemed necessary by the Administrator to comply with any applicable law or the listing requirements of any principal securities exchange or market on which Shares are then traded&#59; (ii)&#160;to the extent the action is deemed necessary by the Administrator to preserve favorable accounting or tax treatment of this Award for the Company&#59; or (iii) to the extent the Administrator determines that such action does not materially and adversely affect the value of this Award or that such action is in the best interest of you or any other person who may then have an interest in this Award.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">This Award may be executed in counterparts.</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Award is granted under and governed by the terms and conditions of the Plan.  The terms of the Plan to the extent not stated herein are expressly incorporated herein by reference and in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the event of any conflict between this Award and the Plan, the terms of the Plan shall govern, control and supersede over the provisions of this Award.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BY ACCEPTING THIS AWARD, YOU AGREE TO ALL OF THE TERMS AND CONDITIONS DESCRIBED HEREIN AND IN THE PLAN.  YOU ALSO ACKNOWLEDGE RECEIPT OF THE PLAN.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PETMED EXPRESS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PARTICIPANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">______________</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;EXECUTIVE&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;EMPLOYEE&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;POSITION&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; &#160;&#160;&#160;&#160;_______________________</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1 2
<SEQUENCE>4
<FILENAME>exhibit1012formofpsuaward.htm
<DESCRIPTION>EX-10.1 2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ic1d7beb6cb9b4d539e1b79a41c0a16a4_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2024 OMNIBUS INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERFORMANCE STOCK UNIT AWARD</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;PARTICIPANTID&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;FIRSTNAME&#93; &#91;LASTNAME&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear &#91;NAME&#93;&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You have been granted an award of Performance Stock Units (this &#8220;Award&#8221;) of PetMed Express, Inc. (the &#8220;Company&#8221;) under the PetMed Express, Inc. 2024 Omnibus Incentive Plan (the &#8220;Plan&#8221;), effective as of the Grant Date, with the terms and conditions set forth below.  Capitalized terms used in this Award and not defined shall have the meanings given in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Grant Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;GRANT DATE&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Number of Performance Stock Units&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;NUMBER OF PSUs&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Performance Period&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;______&#93; through &#91;_____&#93;.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Earning of Performance Stock Units&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The performance metric that will determine the number of Performance Stock Units you earn will be &#91;INSERT PERFORMANCE GOAL&#93;, measured over the Performance Period, as described below.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The number of Performance Stock Units earned will be determined as follows&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Level of Performance Goal Achievement for the Performance Period</font></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Percentage of Performance Stock Units Earned</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;The number of Performance Stock Units earned for performance goal achievement between the levels indicated above will be linearly interpolated between the corresponding percentages of Performance Stock Units earned indicated above.&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Any Performance Stock Units that are earned based on achievement of the performance goal set forth above will be earned on the date that the Administrator certifies that the applicable performance goal has been reached (the &#8220;Vesting Date&#8221;). Any Performance Stock Units that are not earned by the Vesting Date shall be forfeited as of such day.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If your employment or service with the Company and its Affiliates terminates (voluntarily or involuntarily) before the Vesting Date for any reason other than due to your death or Disability, all then-unearned Performance Stock Units will be immediately and automatically forfeited on the date of such termination.  If your employment or service with the Company and its Affiliates terminates before the Vesting Date due to your death or Disability, the Performance Stock Units will immediately be deemed earned in full.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the terms of Section 18 of the Plan, the Performance Stock Units will not vest upon a Change of Control unless the Administrator, in connection with such Change of Control, expressly provides for the vesting of such Performance Stock Units.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Settlement of Performance Stock Units&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As soon as practicable after your Performance Stock Units are earned due to achievement of the performance goal set forth above or as a result of the termination of your employment or service due to your death or Disability (but in no event than two-and-one-half months from the end of the fiscal year in which the Vesting Date or such termination occurs), the Company will settle such earned Performance Stock Units by issuing in your name certificate(s) or making an appropriate book entry for a number of Shares equal to the number of Performance Stock Units that have been earned.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Transferability of Performance Stock Units&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You may not sell, transfer or otherwise alienate or hypothecate this Award or any of your Performance Stock Units until they have been earned. In addition, by accepting this Award, you agree not to sell any Shares acquired under this Award other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale. The Company also may require you to enter into a stockholder&#8217;s agreement that will include additional restrictions on the transfer of Shares acquired under this Award.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rights as Stockholder&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will not be deemed for any purposes to be a stockholder of the Company with respect to any of the Performance Stock Units (including with respect to voting or dividends) unless and until a certificate for Shares is issued or a book entry made for Shares following the Performance Stock Units being earned.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Market Stand-Off&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Award without the prior written consent of the Company.  Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company.  In no event, however, shall such period exceed one hundred eighty (180) days.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Taxes&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand that you (and not the Company or any Affiliate) shall be responsible for your own federal, state, local or foreign tax liability and any of your other tax consequences that may arise as a result of the transactions contemplated by this Award. You shall rely solely on the determinations of your tax advisors or your own determinations, and not on any statements or representations by the Company or any of its agents, with regard to all such tax matters.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent that the receipt, earning or settlement of the Performance Stock Units, or other event, results in income to you for federal, state or local income tax purposes, you shall deliver to the Company at the time the Company is obligated to withhold taxes in connection with such receipt, earning, settlement or other event, as the case may be, such amount as the Company requires to meet its withholding obligation under applicable tax laws or regulations. If you fail to do so, the Company has the right and authority to deduct or withhold from other compensation payable to you an amount sufficient to satisfy its withholding obligations.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent permitted by the Company at the time a tax withholding requirement arises, you may satisfy the withholding requirement in whole or in part, by electing to have the Company withhold for its own account that number of Shares otherwise deliverable to you upon settlement having an aggregate Fair Market Value on the date the tax is to be determined equal to the tax that the Company must withhold in connection with the earning or settlement of such Performance Stock Units&#59; provided that the amount so withheld shall not exceed the maximum statutory rate to the extent necessary to avoid an accounting charge. Your election must be irrevocable, in writing, and submitted to the Secretary of the Company before the applicable earning or settlement date. The Fair Market Value of any fractional Share not used to satisfy the withholding obligation (as determined on the date the tax is determined) will be paid to you in cash.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Recoupment&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Administrator determines that recoupment of incentive compensation paid to you pursuant to this Award is required under any law or any recoupment or recovery policy of the Company, then this Award will terminate immediately on the date of such determination to the extent required by such law or recoupment or recovery policy and the Administrator may recoup any such incentive compensation in accordance with such recoupment or recovery policy or as required by law.  The Company shall have the right to offset against any other amounts due from the Company to you the amount owed by you hereunder and any withholding amount tendered by you with respect to any such incentive compensation. </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Miscellaneous&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Neither the Plan nor the grant of this Award shall constitute or be evidence of any agreement or understanding, express or implied, that you have a right to continue as an employee of the Company or any of its Affiliates for any period of time, or at any particular rate of compensation.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The Plan and this Award constitute the entire understanding of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements between you and the Company with respect to the subject matter hereof.  You expressly warrant that you are not accepting this Award in reliance on any promises, representations, or inducements other than those contained herein.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">By accepting the grant of the Performance Stock Units, you agree not to sell any Shares acquired in connection with the Performance Stock Units other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale.  </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">As a condition of the granting of this Award, you agree, for yourself and your legal representatives or guardians, that this Award shall be interpreted by the Administrator and that any interpretation by the Administrator of the terms of this Award or the Plan and any determination made by the Administrator pursuant to this Award shall be final, binding and conclusive.  </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Subject to the terms of the Plan, the Administrator may modify or amend this Award without your consent as permitted by Section 15(c) of the Plan or&#58; (i) to the extent such action is deemed necessary by the Administrator to comply with any applicable law or the listing requirements of any principal securities exchange or market on which Shares are then traded&#59; (ii) to the extent the action is deemed necessary by the Administrator to preserve favorable accounting or tax treatment of this Award for the Company&#59; or (iii) to the extent the Administrator determines that such action does not materially and adversely affect the value of this Award or that such action is in the best interest of you or any other person who may then have an interest in this Award.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">This Award may be executed in counterparts.</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Award is granted under and governed by the terms and conditions of the Plan.  The terms of the Plan to the extent not stated herein are expressly incorporated herein by reference and in the event of any conflict between this Award and the Plan, the terms of the Plan shall govern, control and supersede over the provisions of this Award.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BY ACCEPTING THIS AWARD, YOU AGREE TO ALL OF THE TERMS AND CONDITIONS DESCRIBED HEREIN AND IN THE PLAN.  YOU ALSO ACKNOWLEDGE RECEIPT OF THE PLAN.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PETMED EXPRESS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PARTICIPANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;EXECUTIVE&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;EMPLOYEE&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;POSITION&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1 3
<SEQUENCE>5
<FILENAME>exhibit1013formofrsa.htm
<DESCRIPTION>EX-10.1 3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8cf5802165504a67af08bb9a3d041188_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1.3</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2024 OMNIBUS INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RESTRICTED STOCK AWARD</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;PARTICIPANTID&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;FIRSTNAME&#93; &#91;LASTNAME&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear &#91;NAME&#93;&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You have been granted an award (this &#8220;Award&#8221;) of shares of common stock of PetMed Express, Inc. (the &#8220;Company&#8221;) constituting a Restricted Stock Award under the PetMed Express, Inc. 2024 Omnibus Incentive Plan (the &#8220;Plan&#8221;), effective as of the Grant Date, with the terms and conditions set forth below.  Capitalized terms used in this Award and not defined shall have the meanings given in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Grant Date&#58;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;GRANT DATE&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vesting Commencement Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;VESTING COMMENCEMENT DATE&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Number of Shares of Restricted Stock (&#8220;Restricted Shares&#8221;)&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;SHARES GRANTED&#93;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;___&#93; of the Restricted Shares will vest on each of the first &#91;___&#93; anniversaries of the Vesting Commencement Date, provided you are continuously employed by, or in service with, the Company or an Affiliate until the applicable vesting date.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If your employment or service with the Company and its Affiliates terminates (voluntarily or involuntarily) before the Restricted Shares are fully vested for any reason other than due to your death or Disability, all then-unvested Restricted Shares will be immediately and automatically forfeited on the date of such termination.  If your employment or service with the Company and its Affiliates terminates before the Restricted Shares are fully vested due to your death or Disability, the then-unvested Restricted Shares will immediately be deemed vested full.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the terms of Section 18 of the Plan, the Restricted Shares will not vest upon a Change of Control unless the Administrator, in connection with such Change of Control, expressly provides for the vesting of such Restricted Shares.</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Release of Shares&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Unless otherwise determined by the Company, the Restricted Shares will be held in an account at the Company&#8217;s transfer agent pending vesting.  As soon as practical after any Restricted Shares vest, the applicable restrictions on the Restricted Shares will be removed and such Shares will be issued according to your instructions.</font></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Transferability of </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Restricted Shares&#58;</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You may not sell, transfer or otherwise alienate or hypothecate this Award or any of your Restricted Shares until they are vested. In addition, by accepting this Award, you agree not to sell any Shares acquired under this Award other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale. The Company also may require you to enter into a stockholder&#8217;s agreement that will include additional restrictions on the transfer of Shares acquired under this Award that will remain effective after such Shares have vested.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Voting and Dividends&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">While the Restricted Shares are subject to forfeiture, you may exercise full voting rights so long as the applicable record date occurs before you forfeit the Restricted Shares.  Any dividends or other distributions paid with respect to the Restricted Shares for which the record date occurs before you forfeit the Restricted Shares will be held in the custody of the Company and will be subject to the same risk of forfeiture, restrictions on transferability and other terms of this Award that apply to the Restricted Shares with respect to which such dividends or other distributions were made. All such dividends or other distributions shall be paid to you within 45 days following the full vesting of the Restricted Shares with respect to which such dividends or other distributions were made.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Market Stand-Off&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Award without the prior written consent of the Company.  Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company.  In no event, however, shall such period exceed one hundred eighty (180) days.</font></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Taxes&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand that you (and not the Company or any Affiliate) shall be responsible for your own federal, state, local or foreign tax liability and any of your other tax consequences that may arise as a result of the transactions contemplated by this Award. You shall rely solely on the determinations of your tax advisors or your own determinations, and not on any statements or representations by the Company or any of its agents, with regard to all such tax matters.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand that you may alter the tax treatment of the Shares subject to this Award by filing an election under Section 83(b) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Such election may be filed only within thirty (30) days after the grant date of this Award. You should consult with your tax advisor to determine the tax consequences of acquiring the Shares and the advantages and disadvantages of filing the Code Section 83(b) election. You acknowledge that it is your sole responsibility, and not the Company&#8217;s, to file a timely election under Code Section 83(b), even if you request the Company or its representatives to make this filing on your behalf.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent that the receipt or the vesting of the Restricted Shares, or the payment of dividends or other distributions on the Restricted Shares, or any other event, results in income to you for federal, state or local income tax purposes, except as otherwise provided in the following paragraph, you shall deliver to the Company at the time the Company is obligated to withhold taxes in connection with such receipt, vesting, payment or other event, as the case may be, such amount as the Company requires to meet its withholding obligation under applicable tax laws or regulations. If you fail to do so, the Company has the right and authority to deduct or withhold from other compensation payable to you an amount sufficient to satisfy its withholding obligations.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If you do not make an election under Code Section 83(b) in connection with this Award, then, to the extent permitted by the Company at the time a tax withholding requirement arises, you may satisfy the withholding requirement in whole or in part, by electing to have the Company withhold for its own account that number of Restricted Shares otherwise deliverable to you from escrow hereunder on the date the tax is to be determined having an aggregate Fair Market Value on the date the tax is to be determined equal to the tax that the Company must withhold in connection with the vesting of such Restricted Shares&#59; provided that the amount so withheld shall not exceed the maximum statutory rate to the extent necessary to avoid an accounting charge. Your election must be irrevocable, in writing, and submitted to the Secretary of the Company before the applicable vesting date. The Fair Market Value of any fractional Share not used to satisfy the withholding obligation (as determined on the date the tax is determined) will be paid to you in cash.</font></div></td></tr></table></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.118%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.058%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Miscellaneous&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">Neither the Plan nor the grant of this Award shall constitute or be evidence of any agreement or understanding, express or implied, that you have a right to continue as an employee of the Company or any of its Affiliates for any period of time, or at any particular rate of compensation.</font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">The Plan and this Award constitute the entire understanding of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements between you and the Company with respect to the subject matter hereof.  You expressly warrant that you are not accepting this Award in reliance on any promises, representations, or inducements other than those contained herein.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">By accepting this Award, you agree not to sell any Shares acquired in connection with this Award other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale.  </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">As a condition of the granting of this Award, you agree, for yourself and your legal representatives or guardians, that this Award shall be interpreted by the Administrator and that any interpretation by the Administrator of the terms of this Award or the Plan and any determination made by the Administrator pursuant to this Award shall be final, binding and conclusive.  </font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">Subject to the terms of the Plan, the Administrator may modify or amend this Award without your consent as permitted by Section 15(c) of the Plan or&#58; (i) to the extent such action is deemed necessary by the Administrator to comply with any applicable law or the listing requirements of any principal securities exchange or market on which Shares are then traded&#59; (ii)&#160;to the extent the action is deemed necessary by the Administrator to preserve favorable accounting or tax treatment of this Award for the Company&#59; or (iii) to the extent the Administrator determines that such action does not materially and adversely affect the value of this Award or that such action is in the best interest of you or any other person who may then have an interest in this Award.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:32.15pt">This Award may be executed in counterparts.</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Award is granted under and governed by the terms and conditions of the Plan.  The terms of the Plan to the extent not stated herein are expressly incorporated herein by reference and in the event of any conflict between this Award and the Plan, the terms of the Plan shall govern, control and supersede over the provisions of this Award.  </font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BY ACCEPTING THIS AWARD, YOU AGREE TO ALL OF THE TERMS AND CONDITIONS DESCRIBED HEREIN AND IN THE PLAN.  YOU ALSO ACKNOWLEDGE RECEIPT OF THE PLAN.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PETMED EXPRESS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PARTICIPANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">______________</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;EXECUTIVE&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;EMPLOYEE&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;POSITION&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; &#160;&#160;&#160;&#160;_______________________</font></div><div style="height:59.04pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1 4
<SEQUENCE>6
<FILENAME>exhibit1014formofstockopti.htm
<DESCRIPTION>EX-10.1 4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i5dc58d92d733490983572d209f539ab1_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1.4</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2024 OMNIBUS INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">STOCK OPTION AWARD</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;PARTICIPANTID&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;FIRSTNAME&#93; &#91;LASTNAME&#93;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear &#91;NAME&#93;&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You have been granted an option (this &#8220;Option&#8221;) to purchase shares of the common stock of PetMed Express, Inc. (the &#8220;Company&#8221;) under the PetMed Express, Inc. 2024 Omnibus Incentive Plan (the &#8220;Plan&#8221;), effective as of the Grant Date, with the terms and conditions set forth below.  Capitalized terms used in this Option and not defined shall have the meanings given in the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Grant Date&#58;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;GRANT DATE&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Type of Option&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Nonqualified Stock Option&#93;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;Incentive Stock Option&#93;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Number of Option Shares&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;NUMBER OF OPTION SHARES&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Exercise Price per Share&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$&#91;EXERCISE PRICE&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Vesting Schedule&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Option will vest and become exercisable with respect to &#91;___&#93; of the total Option Shares on each of the first &#91;__&#93; anniversaries of the Vesting Commencement Date, provided that you are continuously employed by, or in the service of, the Company or an Affiliate through such the applicable vesting date.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If your employment or service with the Company and its Affiliates terminates (voluntarily or involuntarily) before the Option is fully vested for any reason other than due to your death or Disability, the Option shall be immediately and automatically forfeited on the date of such termination with respect to any Option Shares for which it is not then vested.  If your employment or service with the Company and its Affiliates terminates before the Option is fully vested due to your death or Disability, the Option will immediately be deemed vested full.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notwithstanding the terms of Section 18 of the Plan, the Option will not vest upon a Change of Control except to the extent the Administrator, in connection with such Change of Control, expressly provides for the vesting of the Option.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Termination Date&#58; </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Option expires at, and cannot be exercised after, the earliest to occur of&#58;</font></td></tr></table></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.493%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The tenth (10th) anniversary of the Grant Date (or the fifth (5th) anniversary of the Grant Date to the extent this Option is an Incentive Stock Option and you own (or are treated as owning) stock possessing more than 10 percent of the total combined voting power of all classes of stock of the corporation employing you or of any related corporation of such corporation)&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">12 months after your termination of employment or service as a result of death or Disability&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Your termination of employment or service for Cause&#59; or</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">90 days after your termination of employment or service for any other reason.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Manner of Exercise&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You may exercise this Option only if it has not been forfeited or has not otherwise expired, and only to the extent this Option is vested.  To exercise this Option, you must comply with such exercise and notice procedures as the Administrator may establish from time to time, including, without limitation, payment of the exercise price and any applicable tax withholding amounts.  Unless otherwise determined by the Administrator, the payment of the exercise price and applicable tax withholding amounts may be made at your election (i) in cash or its equivalent (e.g., by check), (ii) in Shares having a Fair Market Value equal to the aggregate exercise price for the Shares being purchased and satisfying such other requirements as may be imposed by the Administrator (provided that such Shares have been held by the Participant for no less than six months or such other period, if any, as established from time to time by the Administrator to avoid adverse accounting treatment under generally accepted accounting principles), (iii) partly in cash and partly in such Shares, or (iv) by having the Company withhold from the Shares otherwise issuable upon exercise a whole number of shares with a Fair Market Value equal to the exercise price and applicable tax withholding amounts and issuing the net number of remaining Shares to you&#59; provided that, if the whole number of Shares does not exactly equal the exercise price and applicable tax withholding amounts, then the Company will withhold the whole number of Shares necessary to cover such amounts and will issue a check to you equal to the Fair Market Value of any fractional Share not needed.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A properly completed notice of stock option exercise (or such other notice as is prescribed) will become effective upon receipt of the notice and any required payment by the Company (or its designee)&#59; provided that the Company may suspend exercise of the Option pending its determination of whether your employment will be or could have been terminated for Cause and, if such a determination is made, your notice of stock option exercise (or such other notice as is prescribed) will automatically be rescinded.  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If, following your death, your beneficiary or heir, or such other person or persons as may acquire your rights under this Option by will or by the laws of descent and distribution, wishes to exercise this Option, such person must contact the Company and prove to the Company&#8217;s satisfaction that such person has the right and is entitled to exercise this Option.  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Your ability to exercise this Option, or the manner of exercise or payment of withholding taxes, may be restricted by the Company if required by applicable law or by the Company&#8217;s trading policies as in effect from time to time.  </font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Transferability&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You may not sell, transfer or otherwise alienate or hypothecate this Option. In addition, by accepting this Option, you agree not to sell any Shares acquired under this Option other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale. The Company also may require you to enter into a stockholder&#8217;s agreement that will include additional restrictions on the transfer of Shares acquired under this Option.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Rights as Stockholder&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You will not be deemed for any purposes to be a stockholder of the Company with respect to the Option or any of the Shares subject to the Option (including with respect to voting or dividends) unless and until a certificate for Shares is issued (or appropriate book entry made) upon exercise of the Option.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Market Stand-Off&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with any underwritten public offering by the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as amended, you agree that you shall not directly or indirectly sell, make any short sale of, loan, hypothecate, pledge, offer, grant or sell any option or other contract for the purchase of, purchase any option or other contract for the sale of, or otherwise dispose of or transfer or agree to engage in any of the foregoing transactions with respect to, any Shares acquired under this Option without the prior written consent of the Company.  Such restriction shall be in effect for such period of time following the date of the final prospectus for the offering as may be determined by the Company.  In no event, however, shall such period exceed one hundred eighty (180) days.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Recoupment&#59; Rescission of Exercise&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Administrator determines that recoupment of incentive compensation paid to you pursuant to this Option is required under any law or any recoupment or recovery policy of the Company, then this Option will terminate immediately on the date of such determination to the extent required by such law or recoupment or recovery policy, any prior exercise of this Option may be deemed to be rescinded, and the Administrator may recoup any such incentive compensation in accordance with such recoupment or recovery policy or as required by law.  The Company shall have the right to offset against any other amounts due from the Company to you the amount owed by you hereunder and any exercise price and withholding amount tendered by you with respect to any such incentive compensation.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Taxes&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand that you (and not the Company or any Affiliate) shall be responsible for your own federal, state, local or foreign tax liability and any of your other tax consequences that may arise as a result of the transactions contemplated by this Option.  You shall rely solely on the determinations of your tax advisors or your own determinations, and not on any statements or representations by the Company or any of its agents, with regard to all such tax matters.  To the extent that the receipt, vesting or exercise of this Option, or other event, results in income to you for federal, state or local income tax purposes, you shall deliver to the Company at the time the Company is obligated to withhold taxes in connection with such receipt, vesting, exercise or other event, as the case may be, such amount as the Company requires to meet its withholding obligation under applicable tax laws or regulation.  If you fail to do so, the Company shall not be obligated to deliver any Shares to you and shall have the right and authority to deduct or withhold from other compensation payable to you an amount sufficient to satisfy its withholding obligations.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">To the extent permitted by the Company at the time a tax withholding requirement arises, you may satisfy the withholding requirement in whole or in part, by electing to have the Company withhold for its own account that number of Shares otherwise deliverable to you upon exercise having an aggregate Fair Market Value on the date the tax is to be determined equal to the tax that the Company must withhold in connection with the exercise&#59; provided that the amount so withheld shall not exceed the maximum statutory rate to the extent necessary to avoid an accounting charge. The Fair Market Value of any fractional Share not used to satisfy the withholding obligation (as determined on the date the tax is determined) will be paid to you in cash.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notice of Disqualifying Disposition&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If this Option is designated as an Incentive Stock Option and you sell Shares that were acquired through the exercise of this Option within two years from the Grant Date or one year from the date of exercise, you must notify the Administrator of the sale to permit proper treatment of the compensation expense.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Miscellaneous&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">No individual may exercise this Option, and no Shares subject to this Option will be issued, unless and until the Company has determined to its satisfaction that such exercise and issuance will comply with all applicable federal and state securities laws, rules and regulations of the Securities and Exchange Commission, rules of any stock exchange on which Shares may then be traded, or any other applicable laws.  In addition, if required by underwriters for the Company, you agree to enter into a lock-up agreement with respect to any Shares acquired or to be acquired under this Option.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Neither the Plan nor the grant of this Option shall constitute or be evidence of any agreement or understanding, express or implied, that you have a right to continue as an employee of the Company or any of its Affiliates for any period of time, or at any particular rate of compensation.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">The Plan and this Option constitute the entire understanding of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements between you and the Company with respect to the subject matter hereof.  You expressly warrant that you are not accepting this Option in reliance on any promises, representations, or inducements other than those contained herein.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.307%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.493%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">By accepting the grant of the Option, you agree not to sell any Shares acquired in connection with the Option other than as set forth in the Plan and at a time when applicable laws, Company policies or an agreement between the Company and its underwriters do not prohibit a sale.  </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">As a condition of the granting of this Option, you agree, for yourself and your legal representatives or guardians, that this Option shall be interpreted by the Administrator and that any interpretation by the Administrator of the terms of this Option or the Plan and any determination made by the Administrator pursuant to this Option shall be final, binding and conclusive.  </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">Subject to the terms of the Plan, the Administrator may modify or amend this Option without your consent as permitted by Section 15(c) of the Plan or&#58; (i) to the extent such action is deemed necessary by the Administrator to comply with any applicable law or the listing requirements of any principal securities exchange or market on which Shares are then traded&#59; (ii) to the extent the action is deemed necessary by the Administrator to preserve favorable accounting or tax treatment of this Option for the Company&#59; or (iii) to the extent the Administrator determines that such action does not materially and adversely affect the value of this Option or that such action is in the best interest of you or any other person who may then have an interest in this Option.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.15pt">This Option may be executed in counterparts.</font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Option is granted under and governed by the terms and conditions of the Plan.  The terms of the Plan to the extent not stated herein are expressly incorporated herein by reference and in the event of any conflict between this Option and the Plan, the terms of the Plan shall govern, control and supersede over the provisions of this Option.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BY ACCEPTING THIS OPTION, YOU AGREE TO ALL OF THE TERMS AND CONDITIONS DESCRIBED HEREIN AND IN THE PLAN.  YOU ALSO ACKNOWLEDGE RECEIPT OF THE PLAN.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">PETMED EXPRESS, INC.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PARTICIPANT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">______________</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">_________&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;___________________________&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;EXECUTIVE&#93;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;EMPLOYEE&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#91;POSITION&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; &#160;&#160;&#160;&#160;_______________________</font></div><div style="height:58.32pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>7
<FILENAME>exhibit102non-employeedire.htm
<DESCRIPTION>EX-10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ife6180a1c12b4489a53ee2a99b7a7c24_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Aptos',san-serif;font-size:11pt;font-weight:400;line-height:120%">Exhibit 10.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">PETMED EXPRESS, INC. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(Revised as of August 8, 2024)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:40.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Non-employee members of the board of directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) of PetMed Express, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Program</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each member of the Board who is not an employee of the Company or any parent or subsidiary of the Company (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) who is entitled to receive such cash or equity compensation, unless such Non-Employee Director declines the receipt of such cash or equity compensation by written notice to the Company. This Program shall remain in effect until it is revised or rescinded by further action of the Board. This Program may be amended, modified or terminated by the Board at any time in its sole discretion. The terms and conditions of this Program shall supersede any prior cash and&#47;or equity compensation arrangements for service as a member of the Board between the Company and any of its Non-Employee Directors. No Non-Employee Director shall have any rights hereunder, except with respect to equity awards to be automatically granted pursuant to the Program. </font></div><div style="margin-bottom:12pt;padding-right:75.15pt;text-align:justify;text-indent:43.7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Retainers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Non-Employee Director shall receive an annual retainer of $50,000 for service on the Board.  For any fiscal year beginning on April 1, 2025 or after, a Non-Employee Director serving as Chair of the Board or Lead Independent Director shall receive, in lieu of the retainer in the preceding sentence, an annual retainer of $75,000 for such service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Additional Annual Retainers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. In addition, each Non-Employee Director shall receive the following additional annual retainers, as applicable&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:122.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Audit Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Non-Employee Director serving as Chairperson of the Audit Committee shall receive an additional annual retainer of $20,000 for such service. A Non-Employee Director serving as a member of the Audit Committee (other than the Chairperson) shall receive an additional annual retainer of $10,000 for such service.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:122.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Compensation and Human Capital Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Non-Employee Director serving as Chairperson of the Compensation and Human Capital Committee shall receive an additional annual retainer of $15,000 for such service. A Non-Employee Director serving as a member of the Compensation and Human Capital Committee (other than the Chairperson) shall receive an additional annual retainer of $7,500 for such service.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Governance and Nominating Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Non-Employee Director serving as Chairperson of the Corporate Governance and Nominating Committee shall receive an additional annual retainer of $10,000 for such service. A Non-Employee Director serving as a member of the Corporate Governance and Nominating Committee (other than the Chairperson) shall receive an additional annual retainer of $5,000 for such service.</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Payment of Retainers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The annual retainers described in Sections 1(a) and 1(b) shall be earned on a quarterly basis based on a calendar quarter and shall be paid by the Company in arrears not later than the fifteenth day following the end of each calendar quarter. In the event a Non-Employee Director does not serve as a Non-Employee Director, or in the applicable positions described in Section 1(a) or 1(b), for an entire calendar quarter, the retainer paid to such Non-Employee Director shall be prorated for the portion of such calendar quarter actually served as a Non-Employee Director, or in such position, as applicable. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:40.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Equity Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Non-Employee Directors shall be granted the equity awards described below. The awards described below shall be granted under and shall be subject to the terms and provisions of the PetMed Express, Inc. 2024 Omnibus Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Equity Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or any other applicable Company equity incentive plan then-maintained by the Company, and shall be granted subject to the execution and delivery of award agreements, including attached exhibits, in substantially the forms previously approved by the Board. All applicable terms of the Equity Plan apply to this Program as if fully set forth herein, and all grants of stock awards hereby are subject in all respects to the terms of the Equity Plan and the applicable award agreement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Initial Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Non-Employee Director who is initially appointed to the Board  prior to the next annual shareholders meeting shall be automatically granted, on the date appointed to the Board, the annual Subsequent Award (as defined below) grant of 7,500 Restricted Stock Units (as defined in the Equity Plan), prorated for the time actually to be served as a Non-Employee Director from the date of appointment until the date of the next annual shareholder meeting (provided that if the date of the next annual shareholder meeting has not been selected at the time of grant, such prorated number of Restricted Stock Units will be calculated assuming that the next annual shareholder meeting will be held on the anniversary of the most recent prior annual shareholder meeting).  The awards described in this Section 2(a) shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Initial Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#8221;  A Non-Employee Director elected for the first time to the Board at an annual meeting of the Company&#8217;s shareholders shall only receive a Subsequent Award on the date of such election and shall not receive an Initial Award.</font></div><div style="text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Subsequent Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. A Non-Employee Director who (i) is serving on the Board as of the date of any annual meeting of the Company&#8217;s shareholders, and (ii) will continue to serve as a Non-Employee Director immediately following such meeting, shall be automatically granted on the date of such meeting 7,500 Restricted Stock Units under the Equity Plan, or any other applicable Company equity incentive plan then-maintained by the Company. The awards described in this Section 2(b) shall be referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">Subsequent Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.&#8221; </font></div><div style="text-align:justify;text-indent:81.6pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment of Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Members of the Board who are employees of the Company or any parent or subsidiary of the Company who subsequently terminate their employment with the Company and any parent or subsidiary of the Company and remain on the Board will not receive an Initial Award pursuant to Section 2(a) above, but to the extent that they are otherwise entitled, will receive, after termination from employment with the Company and any parent or subsidiary of the Company, Subsequent Awards as described in Section 2(b) above. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Awards Granted to Non-Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Each Initial Award shall vest on the first anniversary of the date of the Non-Employee Director&#8217;s appointment to the Board, subject to the Non-Employee Director continuing in service on the Board through such vesting date. Each Subsequent Award shall vest on the first (1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">st</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the date of grant, subject to the Non-Employee Director continuing in service on the Board through the vesting date. Unless the Board otherwise determines, no portion of an Initial Award or Subsequent Award which is unvested at the time </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of a Non-Employee Director&#8217;s termination of service on the Board shall become vested thereafter. Upon a Non-Employee Director&#8217;s death or disability, or upon a Change of Control (as defined in the Equity Plan), all outstanding equity awards granted under the Equity Plan, and any other equity incentive plan maintained by the Company, that are held by a Non-Employee Director shall become fully vested, irrespective of any other provisions of the Equity Plan or any award agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:81.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Changes to Form of Equity Awards in the Future</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Notwithstanding the provisions of this Section 2, the Board may, in its discretion, determine that any Initial Awards or Subsequent Awards to be granted in the future may be granted, in whole or in part, in the form of alternative equity awards to the extent permitted by the Equity Plan, such as restricted stock, in such manner as the Board may determine.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:40.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Reimbursements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall reimburse each Non-Employee Director for all reasonable, documented, out-of-pocket travel and other business expenses incurred by such Non-Employee Director in the performance of his or her duties to the Company in accordance with the Company&#8217;s applicable expense reimbursement policies and procedures as in effect from time to time. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * * * *</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>pets-20240808.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:270fcfd2-e9f9-4153-be8a-0c4ee1f4cdd2,g:ff2e6c25-9265-4d81-8a2c-4b3c972b0ebd-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pets="http://www.1800petmeds.com/20240808" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.1800petmeds.com/20240808">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20240808_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pets-20240808_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.1800petmeds.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>pets-20240808_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:270fcfd2-e9f9-4153-be8a-0c4ee1f4cdd2,g:ff2e6c25-9265-4d81-8a2c-4b3c972b0ebd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_5e802806-fa98-4da0-9729-83e875f40387_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8a0e2740-2086-4b5d-85e2-b5c295fdba2e_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_0e2ee8f8-e162-4235-bc98-019e6c6cc4b7_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_13cab97e-ec86-40cf-a2b2-989c66425a99_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c20fee98-aed7-4ee0-8e60-8cbd2c722612_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_396db1f4-94e5-41d7-8a12-072bc88f0305_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_fbe54d5c-21fd-4567-80eb-45653a7f3b14_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_a78e3bb8-3f70-4e04-9f53-d86e1ff6a464_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_c1da454f-0d4e-48b8-bad3-4cc9889f96a4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_dc33b8ea-d32f-4fcf-a859-e5b557df43b4_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_751e4a15-f603-4a9e-af1e-ed8fd84ecd29_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_4d049840-ca8a-49c9-b8ec-01b6da3efc9c_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7cea7721-d011-4f3c-95d2-fdb30da17abe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_66400f2a-667d-4b50-935c-5a20bacc840a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_844380d0-caa6-484c-be68-280109ace534_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_2a9a023c-63c6-4bf4-aaab-018adf2d8c1e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_01df8b31-d793-46ee-bd95-7f1b64a6d1ce_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_65648325-ca83-4a4b-a563-70c178fa15e3_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9fc82402-bd92-4b2b-81dd-3c8adfc5dccf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f3d7efc2-ec75-481b-8c44-9d91660a1ed9_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_19e5c5a5-a36c-4222-95ee-02f30aa0705c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_33311214-1998-45e7-a185-482b26c0918e_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>pets-20240808_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:270fcfd2-e9f9-4153-be8a-0c4ee1f4cdd2,g:ff2e6c25-9265-4d81-8a2c-4b3c972b0ebd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.1800petmeds.com/role/Cover" xlink:type="simple" xlink:href="pets-20240808.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.1800petmeds.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_167fcee3-5768-4b12-85db-9aa334d824f5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_DocumentType_167fcee3-5768-4b12-85db-9aa334d824f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_e8286a07-e236-4216-87af-5c980c953731" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_DocumentPeriodEndDate_e8286a07-e236-4216-87af-5c980c953731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_552d2fbf-2965-43ac-a9bd-0b9a0903a86e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityRegistrantName_552d2fbf-2965-43ac-a9bd-0b9a0903a86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e806dc8f-906b-4c5c-a577-60eaa3868f54" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e806dc8f-906b-4c5c-a577-60eaa3868f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_87c6dd2a-4c23-4764-8372-cc64c3d1ff14" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityFileNumber_87c6dd2a-4c23-4764-8372-cc64c3d1ff14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f0eb18bc-54b1-4fec-97ae-943c368e2706" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityTaxIdentificationNumber_f0eb18bc-54b1-4fec-97ae-943c368e2706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ac1b52c1-4013-4d9c-b48d-addd30b2e737" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityAddressAddressLine1_ac1b52c1-4013-4d9c-b48d-addd30b2e737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_caa4cbd6-701b-4f9f-83d4-e57fff25ab71" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityAddressCityOrTown_caa4cbd6-701b-4f9f-83d4-e57fff25ab71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_4d29241b-6c12-485c-a87d-61939ab5113c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityAddressStateOrProvince_4d29241b-6c12-485c-a87d-61939ab5113c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d0e0672a-16b2-4891-9812-9fbca6b29907" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityAddressPostalZipCode_d0e0672a-16b2-4891-9812-9fbca6b29907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e00d4203-9f6b-41a6-823c-3ca513955ea5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_CityAreaCode_e00d4203-9f6b-41a6-823c-3ca513955ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_588b9ba4-a403-4be3-9c3c-04a80fb18760" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_LocalPhoneNumber_588b9ba4-a403-4be3-9c3c-04a80fb18760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_84fd6f03-3dcb-4360-b6a6-4080c3366309" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_WrittenCommunications_84fd6f03-3dcb-4360-b6a6-4080c3366309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_812a4247-dbe0-4531-bfb3-fb00b1e36209" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_SolicitingMaterial_812a4247-dbe0-4531-bfb3-fb00b1e36209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_76cce46f-081b-4125-8cd0-0ce7fc7604c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_PreCommencementTenderOffer_76cce46f-081b-4125-8cd0-0ce7fc7604c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f25e06ed-2730-4ac8-a3ea-be7300b6311c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f25e06ed-2730-4ac8-a3ea-be7300b6311c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_85111d47-682d-45c6-9be1-bb74ab9d713c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_Security12bTitle_85111d47-682d-45c6-9be1-bb74ab9d713c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_06b2410a-61ea-4d5b-8b68-27ce3b3b0ebb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_TradingSymbol_06b2410a-61ea-4d5b-8b68-27ce3b3b0ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_5f1d7182-484a-407c-9a47-db5603c8ce25" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityEmergingGrowthCompany_5f1d7182-484a-407c-9a47-db5603c8ce25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3d0ec63a-2101-4fb4-b5b4-b1a047b491ff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_EntityCentralIndexKey_3d0ec63a-2101-4fb4-b5b4-b1a047b491ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_7575c71f-2a66-4cf4-ad16-149502a442e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_AmendmentFlag_7575c71f-2a66-4cf4-ad16-149502a442e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6d2a8b2d-f81d-4815-8870-545bc5f60bba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_77f86c46-5dc3-43a8-8dda-a0bdd4eced72" xlink:to="loc_dei_SecurityExchangeName_6d2a8b2d-f81d-4815-8870-545bc5f60bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140434606397440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 08, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  08,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PetMed Express, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-28827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0680967<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">420 South Congress Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Delray Beach<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">526-4444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PETS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001040130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( &&*"%F7BKL<P
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MCEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0    ( &&*"%DD'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ 88H(6>YLS=[N    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M88H(69E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " !AB@A96U[=O40$  "&$   &
M    @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M88H(69^@&_"Q @  X@P   T              ( !APP  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " !AB@A9EXJ[',     3 @  "P              @ %C
M#P  7W)E;',O+G)E;'-02P$"% ,4    " !AB@A9JL0B%C,!   B @  #P
M            @ %,$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 88H(
M620>FZ*M    ^ $  !H              ( !K!$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ 88H(6660>9(9 0  SP,  !,
M         ( !D1(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  VQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="pets-20240808.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.1800petmeds.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="pets-20240808.htm">pets-20240808.htm</File>
    <File>pets-20240808.xsd</File>
    <File>pets-20240808_lab.xml</File>
    <File>pets-20240808_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "pets-20240808.htm": {
   "nsprefix": "pets",
   "nsuri": "http://www.1800petmeds.com/20240808",
   "dts": {
    "inline": {
     "local": [
      "pets-20240808.htm"
     ]
    },
    "schema": {
     "local": [
      "pets-20240808.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "pets-20240808_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pets-20240808_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.1800petmeds.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20240808.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "pets-20240808.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.1800petmeds.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001040130-24-000081-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001040130-24-000081-xbrl.zip
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M. B?'XU?BN?C\4M^*(+#@^CHX.#H^>N7XN#/]A.8"L/M'&V6L?CER4PFS:G
M^Q\?':;F9"%#,SUN'QS\WY/:.".N3)/'<I(<_SO71D9+N!ZIQ  =&:QK/]KE
MUVY2F4Q;=5/]Y4#%*CO^Z8#^G."59L1G,EX>_Z.321[_HZ%YHIM:9#*RE[7\
MCSAN([WT=6$W\!QFQS(1?D/M0]Q%[VHJQ]*P]D&KW6K7*=U,8P#,%MGV_=U@
MUK=NK;VRM:/5K=$!7?1&9[U3UOO7Q65O.&RP_J#;NG^DTBF0<)^?#?KO/@Z1
MSMY@U/^]QRX^= ;WE&)@Z>BRWQT!@X>C\^X_V<=!?\0Z?W0N3]<HOJ6HU#7H
M>V]GLQK\_-/K]LE%YW+4[_8O.L#]4_CEV<F])O?7_N5P-.B<]8A41K]]Z%1^
MNCWU]_J,3@7/["Z+'?[\TXM7CVV;GU3.IGPNV%B(A$TRGJ!WY GC"YZ%3$7L
M4FB3R0!_'AH5?&8?$VDTVS-3J8%!KPX/#TXZ.)@^MT_V<=*%,&<PH7>59D)K
ML(9)T,(IPL_HJEG*DV4Q)T]"D3$<L'&J-5FS1(YSC;^ "9) ]$4,E%:7Q1_\
MF@TFHD@$-)!KI H'OL<MLE,  0VVD&9*/X(]FVG8=<@"E8322)5HIH5AD<I@
MR%C$:M%BK,M3:>"L_@/TV2FYAH\R8<0,X@*MDBC#0A$!MT.FISR.+8_Q5C/!
M$X >FDV KL3.M1NYD;OX9M$R?!P+/V*L,F![$T0LYJD6Q_[#22AU&O/EL4Q(
M9&C2R8QG$X H8V6,FAV_ /F:B\S(@,?N+G1#>[D$+ZT#"V ,4&I"?V=WN467
MGIIP_=KAZU:[_6KK94 06Z]=M^S+5ZV#%U^W[/77GA\^O]',I\0(RPS@MP8U
M^.7)LR=^0LK#$.3C^#"]8JC"ZX>XQG65WI7)H),L-8@,XL\_M5\>;/B[$$O'
MD >Y5W( [R_!1[/3SFC%T7UY8P>XK:\[>(;_/FL='=7Y$HMH7>WNF"F_@T?
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M3?OU7QT>OBPX>%=0;X5YAZTV-7\,A'1%?%>O3US^VI4:HFK6W<(#S!,8"5"
M\!HX*T'UQ:!PFV6='*Z7N0_RYZ[%E)#>##PT5E**G AA/.XB"/!^[OD!FWY(
M_!,$8M7KU^/X2F]U482M9?,ID,26!+S"40@AS,DLJ($AU5#DAO'#3A2_ARB.
MJBTC%:FKR)OM_338M%&3*R\1=)QBK:ADJUGY^-_XU>9P& B]('E%? D" JA.
MN,850(/V)I@NBV-78*(;&FKQM!7T0LQUT9]BP]7PVJK^5EI:C%)E91,V[)Z4
ML- /#T$W-?(@[8#M)"=%M-DPP/PS&XVM9,+< S@0D?MD6=G) S&[MH_N<$*M
M2)R\J2;<+M+=J@BWB*UWNO<]=.]=O3NL9OZW)^1NWCJV)9S=UD?R8/K*OKW_
M<J<6]U@M.ECV*-[4X=6!=*/P.ALZ*1M%A084POH8*F#$8D+]@:4MGENAG.2P
M )ANW?#IF17,15T*((DPLY*=JSWIPXKR$B6F_6B;B=@XP1=R_--)];[3NJ;!
MDK72"[@N\)<;EZTVWVS:"+5,--A86M?M7H82Q+D&=NQ4ZI&KU-!!'Y\*+86O
M^C!<7:(PCSQ3(3"5+#AV8&UJ!B(=\_T_^#!2-9M=/'KW8B_8K]X0EJ20ENW)
M_96DIJVRV'F4J*/6SC+5N5'\*6Z!2&59]K35'9-7KEC:M&0E$ZY]" 60,PED
MRN-J5YNX"MPS>\@22E<J_\23=[@V^YE@=384H4W][DFY;U^58E;*<N)K=D?6
M*X-(+>)S95/HE3ROLL5;@Z\_+(MZQ5GY]JCBM4Q((/P&-*ZQ?_WN1:K4%:BK
M!Q0J^!6=] P?))/T*"^9KA"?8:='?6V3%^71?9IWU>;QM5-WH&.,SZJ15:6G
MYVTYS$>>A%<PB*#SL-WE= PVHDW*B;57..U ]:,V=:-2MEP'H+@";38>#^?D
MHR%DW?C<[/6Y_1]=-JS$G;IXFYLK)X/2310H7:71<>-[SRI&&-S^:),W6*TR
MX1,UAHKM-BPE@U=&S%C<SU*554>,L20>P6<,C G<)]LAQJYD<J/C?_[(2R9W
MIT@DW'/G)]&7@'Y$ !:JL6GMC7]UG+2N,!9F6_UKV)YN%:^DN=3<97RI**Q+
M92R;MK:KR,-\_>2[3ZS3[?8NZ#U;H]_Z0_M2UP;[=/Z1==Y?]GIL=,XZ'S[@
M>Y=&O\&WWN49#!J<LN[YX+0_ZI\/ANRT-^Q>]M_U3MEOO<M>?T#7X1^<@&^U
MQ10>KO=A"&MU_SDX_^-#[_1]CUWVNKW^Q<BO34,?&8,WO99XVQO[_NZ_*V^\
MO3,NW^O#>;>\T1L4[PPO$3M"$2C[),XQ 0<<]>3MG[4_=TU9Y?Y_MY#^N?W/
M%]]T><_$:_M&7[=/>O_J=3_B>[_=JXU_C$FXGL2SBP_GGWI?^WKI>\#DB_,A
MN:@'N8.'1N^M][&AE>%'OW3<OT25W=(\[2*G;XN<7GQ=Y/34_K\?3^G_&_E_
M4$L#!!0    ( &&*"%E5;EJ[F4\  (L  @ >    97AH:6)I=#$P,3(P,C1O
M;6YI8G5S:6YC96XN:'1M[7UID]M&ENWW]ROPW-,]9 14HRJM7IXCRK(\HXCV
M$K+<_;Z]2!))%EH@P,92)?K7O[OF H"UV%:!M&HBIETB"2 S<?/F7<X]]ZN+
M=E-\_=6%-=G7_^NK__WH4?)MM>PVMFR396U-:[.D:_)RG?PSL\W[Y-$C^=6K
M:KNK\_5%FYP]/GN:_+.JW^>7AK]O\[:P7^M]OOHO_O=7_T4/^6I19;NOO\KR
MRR3/_L]G^=G9\T7V-'OYV)XNGYIE9IZ<OC!G"_OB<P-_FZ?_[_0SN!1^SM<T
M[:ZP_^>S35X^NK#X_"]>G&W;+Z_RK+WXXO3QX[]^1K_[^JM55;;PL!HNYC_Y
M'H,[M?9#^\@4^;K\8@FCM?5G?*U^OZR*JO[B+X_I_[[$;QZMS"8O=E_\YWF=
MF^(_T\:4S:/&UOF*OV[R7^T7IZ<P*OKGE0P3KB[RTNJP3\]PK#^]?O?]ZV^3
MU__WI[>O?_XY3=[\\.HD'G X:5.O8=Z+JFVK#=P GC#MZ.G5__C]#V^^^>5G
M'/KK']Z]^<?KY*>_G_]PYTGD9083^.+)\VU[KW,X=>M]7\_\<FNR#+;4H\*N
MVB_.GI^\?*J+D-EE59LVK\HO.EB/&B\%(>GJ;=78O_WEV>=?)J]7*[ML\TN;
M? N[,_PLJ<KDISJOZN2G @9WW]/Z[.N3Y #?^M/1H<[,?.+7?G;R[ 5.6E[N
MQQS-^!*<).\N;/*3;;\''?_ZP[:V30,*J%R>L$K_<5/FBZ[!3^ 5H<"A6"6S
M%J[ZVU]>GIT]_A(_H#]/OYPG%Z9)VJLJ65:;;6%1\YMZEVQY>@T(ZLLODUD^
M3]HJ,6U;&Q!84V9);5N3ETG5M4T+_\:C!H0BO\RSSA0-_AKF!P^'NU>K5;ZT
M-8PRRVL0^ K_M/"T:F<M_(FW6U9ETQ5PIU8^F.7\S+S$\ZRQL+C5\OU%5<#V
M2BY-T5E9")S<55X4R;:NX.DVV9JZS9?Y%N^%E_,J--??+%GL<)SP2F BN%35
M=EO5;5?F[8ZFOOQW!X-/F@L#"PX_I1^]@C4SY0[7\O3%EPVNX09V,]T]A25:
M6EQ_^,CRHIH=KF^3+& ,&>Y[O D_'^[8=,N+WBU *>A=*OAM[>=#[\N6#6F=
M5.^UK5K\VA3%+EF92U!*B\(F<+YL8/X7IH7_R1M>,UFNYN[GUF2;?W$HFS]6
MYI/I "?Z"SA_-C:Q.BS>0N=7ILZ:9&-V\(-D7<.&0+,0#R@O!R0Z^&NS:NES
MVSNJ3I+>PU":\A*^P;TM4I2!8"8_XU5PM]-GQW2B+*<6JB<GIR^]4-VC-;!/
MMN3YH/6&TI"&>@_.#GKQ+'?T33!TN-&/Y=Y;!#_T$I6Q#B1-559)::\2PT*\
MK+HB"\48M:$E609A+]J+JEM?Z(_U-]MP'N=;E%53T!AD%YA@&+0)FA8E/#S4
MC%/V\2QX+\"QU>8EJ&]X" RNZ1;_HI6  P-WRH7J7CGBLAPWB+NC?_@A*N$]
MOL/AV]W?VE5>\DI/:4S?WY9]9;9Y"][DK[@O2-XZM"]0Z,JJ9<OA*@>S)\.5
M867M#H#[7Z()5JA"RRE!E46'8F+6M25;%U08;&C<C*NJ**HKW/(;:TKX+]N^
M]SW6ZP3[B$[5C^NGC2[<N*DF+L_]2_EY!F=:WH#'! [/_4N\^'<DS T)^#<5
M2GY5ZPF^R=O62B3BHXR/[O,%::;E+4:LIN3]K]5!3!^-GON?>JKF$6@+5(?[
M!84"!9DM[)H,-=.!S56C=\S1@&8+QVV^R OZ""V>)-H!SN9!4PN>"3XQ/F)3
MU>3*\C.:A'[(X8*>DTW>!AJ*+3X>W'5Q-_[VE]/GC[]\ LYAZ@PN#71$(] =
M 2X\V&:F:"K:'-[MIB',FCG.Z&]_>?KB2S\8^/003;1)_.2C4+[PVHI\$M]<
MQ8SB:B"/8DV ^"[K?($66B5>#@HJ6"5ON\(FIV>+1V?.-P=GX\/RPI1K<%N6
M[4GR0]5>Y>V%<TK87JGMNH)_I?BG"]CAKLDL>U3\4_BT'YJ[NJ@VN$-_W)+#
M7J$G]#-&G,A+LLN<3(_D+26*XOC!R";3M8Z/'-RR&(O"^!FH-@W^%3O6+#4Y
M;*$6R#$/LK%9;NH<PX)Y0^Y5#789;W@TXAI9(PF3R0\27)W8-<5/\C)Z [ R
MKZK,JN)HDJ>G3V&OX'UGR_GA'83)5$<"FLK;;;'#12-1I1$UN&:\R-N+&J.H
M(@#@K!?6-)A21 V- <I8UX+TD$,"]]T69DG!SOZU+P?76H-/IM_G+0[(FKIA
MOS\O'R),=U#'&F&:3AV#-.5+BD6K8CL$B[@D-6>*I+'+#FP94#M@!XGB1:78
M@021M0,6!"G>9M>T=H,QNJN+G")55A1GCK'0O,2\ P;?\0*TDMBB,G[^;;ZQ
M1V1*9%/+[O2F! 8,II96P\<O*DX^LT$1[SNPX:NW%FS>?(F2^S,GDOJ?)+^4
M.?[R)UN#]; QY=+&7\AU)GEEFHL@F4C+08DI/&4Y*=7NMJ33*?P:&.F]5,,Q
MZ6S[R<L]>8%3RWW@CJZ2;S5[W/,,CTFN5E/+U;.3YT\FE:LQ?3*UF)F$,7'H
M&VF^W21+'*GD['MADE!M_G>%7I4!#P8,UMQ>@N*;8>2 5&-M"3? :7_\S<:V
M\S2A4(HZA&'J]/%^VR#$S8&K1PF.+VI;&%S' 9).KQ+1?^PO,8NF*KIV_R4?
M"YQV=JLW<SI8@!M @?R_%[4.;VO6]M&BMN;](\II?V&**[-K/OM(0,2#4S'K
MJ57,Y$?7*]--@<R*=$I*$0@*C&I&./G)(Y-2#GVLXM13*FX%*HHB;UI6#E6-
M9A3\EO+9>;N+$E.W$<CH_:!$3BRB^=0B^OSD["E..@P/K4&-EA3["%^4PW8Q
M8 T5.2*["&:%P"OU%E<:BTK!F[RT-1T-< PT.<S U$'&D>0B#%6)+1W$T3 2
MA=&N55*BF,"/RZ-^W9._[R<G+_>^;@*'Q%GA/^$;F/P5G)[PM/>^@SZ8TF^X
M9%L5L!UM@W:3QQM)< 4C*JI)-?+-[O",W^#P"XP$XQF!49N%I9R_R:R+&5]5
MR8Z"C1X3 'ZPV^BO=*/_<5/)-Q3X;FVQBU%+@Z?._WRR>3FU:#X^>>%.@VJY
M[.K:EARE)O7<.Z0%$OUA3A_7=LOE-BN3%UUM&;*[ZAI3N)2G/TWPM?*-Z)O"
M7*VZ0C(C!%+NY3SI:/ G0S*S'Y9VVR890\Z:?/F^)/QW7OZKJ^GW6=X82L."
MD(&G,=O-DW5=-2AMII5C"Z_-NG87AW$0T0;#(>#R^P)NBU_3M2"5I5V#1X 2
MC AP<G V>=/(S>"S.:9H>M,5>R;5?;&N*EHH. #_U65KVA#QC%-!^H'=U!4M
MG\88@L4WKI/4K;%GC?)R6704K5UT+0&@"CB#6\Z\C;ZR^*7X'5HBA+!:VJP;
M8KXI!#;[E86 LL>\&,-%(#E*5K:H>+"\V.#[;7"LEU5Q20JHJF&&;5=O\[;+
MK*;?;[YS22\$_EK!"RZ7N$X@ A>@&1K,Q*]-7C;M=0MV1-'HBZDUA;HVY\ET
MSDW_1)C.T>'LGD/0#0WILF]8I<'!E?KL8(;?TOZT'\#MP5^,:5Y6SLV#^_-'
MN3^XR%M;-^C(@#T2P!(:E[%UV?+3)[-L/GM"\)CD]"G^XVSNP-$!7B&5>@2,
MJRUL:5<Y::7JJ@2]-QM/S#,(XDGVZ(ED#6@LYWBLP+<P P<3B-7P?S816INR
M%F0A';5\3"X@XB_)NT(Q.7N*=4QP<(.\Y)7 0%AV&L23)%<67DZV)T0?&;@+
MB]@5^GIAX5VH###4@&X?E:N]*9?=9H&V@LL N.HU5B%+*NJ:K<2<P1HOM/(Y
M.05R"0K&M!=43X:%9BT<L5B^HM@#-#'^Q6 V&78$@5MH B*:'3X(1KP$.RDP
MU]4XB# <]%N]F!<+=AM:)L9_+-[,WA4949;P#YC;<'E0?]*E[N:S\SD]TQ9V
M&5A"/,T%&S-20E;CW@5=G3E7"<>L,0NC5135*O4+"![3(Y 4K+U01\PM%4X7
M793DWYTI\E6.6?%F9- PN)Q>&)@S'>70X;D+=8<J6 4W(,HH:LC\#*P"W#%2
M-OC-W"UN9IM\S64E<!\CTDH#0G 6A;9)QZ$!6UX7H<&#27Q.S.R7C>%GC\;P
M94"Y\]2.6Q5-KHO"P(%3)PT<'O4:X6BXH<%BS^@]D_-5U6LX5W[55ROB2S+>
MV )S-5CC@T?, @\.*9>D#U=)CGF:IK$M N50IL1<][8S?\#0-A:Z4+EQ&1V?
MI(&DD#M%JN@EGF6\22ZK%C?ZMKJR#A^+6^51>*0%V)2@1G1L,+<9!RS<A2TR
M=<C,&H0> ;VX0[@>UFUAP;4,%7?_IG=R( 8"?J_R_&;EC5+&%S:@I5$+9'9E
M:_PCK*L-"[KHO',XN#Z8,'GZ^/-S,&XN++T06$T4)"[&(7BE.+3D"X+^S/6)
MH$I)*<,]V+)"()'9$5;H4T\%GAU_*G!:<>^V6-R[)W19QC!B+@[+6>Q[MH9!
M>\";#0@MWG0;38:7%HT@PY$9HA%@^.UP@["ZI(![5!N $&,.VXAVT0<&8QJ/
MU,-V:3KX83_9QNX#_O:(PAN3'[7J%TX7W ")F1H,@E+V!G4=(D/?VDN+];TD
MRK"!3C]_^9Q\99'0D^2<' Y0Y10SICPO2B%8NDM_7GAW*-, I6UZ+H3_L6X2
MV)E=8=C[AF\W7<&U-X&'["XZ)A#4OQ[D7,N-#D'87X46CZ_W"EWAM">KKER*
M\?AL99- .G-YY"[L#.=-SS/SWSO'JS&;.'NNU6;,?.$'*?X_VG$-<B<4Y,+_
M4)6/7@O!3.!@SM K7-DKC0I@HF]V-I^32[BQMI54H3MS?)U""7=4RAKGW.I2
M\G[D$-;SQ2.L1<,XV7#+]B-E/529/TA7$GIPQ 3"Y=$[8/TC;_&P(SH(WT^M
M(":OF!!'=VKU,$8SA:#P[V (X'*#,-9;*51WF/ @*,:ZX9B.IF)JR9O\:%)U
M.;7H&?CO9N$#(W1"'),H;286I=//3YZ=32Q* D687(^-0_KR4H;''F,8#=PR
MP#O!2#-H,K1ILHZ"<."'!A^6B (OI 8>K75T9LL268G$)<54!$5SS)**5C/1
MEBM-:)$I4L($8!RSSQ_/D\SL&A]*0MO&+CL"RU?XP':N7";ME2W@T]GIV;R7
MG,'P-N8?P"61X/?2POS!)\%8'QI?\+G$VSDV?K%K,$U7)IM.PN\P7KMMN6@M
M1ES@;)TQ5,%4!61%S'NP1$M8 4QNH).>]N_?: X"/W=N/,7%_(^&!F+X[.M_
M&;QIY2X+(!-L,,++!@.2O;7@%96=:AS[P2A:K-$;!VMDWFL9]@!8YH7>1SO"
M >"9B%-GB_97VTB^I%D658-H%):E@E):N"PT7&(C9'*:#%YB06D:L0C#4ICC
M48_EU"?MY##U;W/:HF!>_;O++TU!I,O3NX-<"A-5PD@1#.&XJ"H&%-'/Q(29
M)A;S>BJ&]&4F\VH"M!-_CC6(BTX"&B8?ANT,W_:(Q+CZY,5X:C+,6(+/NW6'
M= (IL>&FPM!'P,5J')Q+E*Z:^^+\MBIW=K\Y+'!>EBCHWUO;2G;^Y_#"EH\$
MX3<05IF,^#./1YBW#\(<!$RF%F5*POKL;Q0XHE#TDZ>_(Q0=W>XWA:3)4.D*
M^^<*3O_[D]\#WYF\3KXW]7O;)O] <NK)2^G K6%M2V3%PO!-SE9&A+(&44)+
MZ^++$;]VM;4EU=:A@4U_,,(H!3]N3:8,(K\;L+_X+JGBO@QLO(L-J/LE$X4A
M_,(6!:EY_&'#("@>F:/@'N$ZT:\"&I#,$>$B?8-E5B<A&0'_C[\J82/P;ASY
MP>T'63(9K;\8/KLD]EO1#ICAQ9*U-5W%<#-^/>Q5759%)S4V<A.X)]'S!#?5
M!*U<KZ]"((1/'O.#!4("@]=//._T8'FH2IK=JWZF8,!.!\] Q 7Z4;5E7CA$
M7T4XO)2!Q6-K)FNEN%>BKV\=[09+%^/F[0=;+Y%,E3]DS&' I+6/EB/U>/Y6
M*\KY[OCYIP[U>'+T4(][/:6"K<* "*?Q&#[1$_ -FL0+V"1U;2\KOFX?"I?2
M;_OU H:>EAAZH )7\M_>800%"W/>.N,@05;&%U^>GB#JX]$I)L2>S;'2:W8^
MYQ0>C.ZBROIL=8.C9^@A*GPKP*C<4D6@O8)(DRS'1@]P'1P,JLTTVC8<0$XA
MO\BLHE*FFNJ;5!NDR:5M6CI=0'&TA:]V -^YZK14AX:^3S-=,_2LLHQIY3>S
M(^#PBH;4RE*R?AF.GR)K?'@RE[F1 HV,0H&ZBJ2<^( ,SL* _CQ2]5&YHCN_
M+EAQRT5<RCZZH(Q=#EZ<#R+6P9A*P?'0>$*?*C@>_>-Q8(Z8B[<!7QF4J4AU
M']C*;R*0(R^ND':1N9O ZX1]DC<7R$I/OU)JL+3W<OC^;C8H+D&AV_A;R7&@
M,!,\ASE@C"1WBD<4/Q1> 4T6Z]C<!J\(D4@=0&"78V'<C?R0<C(O-:)8B@4D
M"[MRL1PZA8.O6 8B&1D5,%IMOLDQF?KUU*;^LY/'TV9H1H$24_N]QA<R(#!#
M-B<1]N*^=(F'0:DL&H _=PO80LPA>D1AQ&9J49P<\< 6]-2R%P7 MUT-&A^4
M)JLVC 3"D=(:Z2VBUG]@+HF1A**)/(]'I O;J05P<F*R($DWM12:,F!LCC*F
M0^QTF*@ICP[RW$TM=I-'VP94<M,+WRXP,KE.2O^U)JZ[H1!Z8[G9Z[%A8ZD!
M;5Z _&<[%_V4F+/!E9JZ2\=(,G81E[@4<H7&0.H9#X+$Y *[Y&)M%G;Z&XX]
M+C_?D)^K31%+L(#12F[8GUM6#7EYP4?*NX'%T.$G-8/*^:/H'U+F2,T4_576
MU-20QOGLYH,^HO\5D:C;AGLTWN)W*?\H16_8!ZP(9+%!Q,&OQL?2[G2/-+H!
M0T:(NX1J.5J[D8'Q/)-576VTFQ:YY%KO*3_#Q1Y=$@P-4P://\]R#')E>[]O
MJQ8U:M#^L;9M5\L,!\Z-O%K,7J] "/Q8F!M277@DIW=O#HOB+BEE<\>?<Y&@
M^[D6X.>EA!8&=Z85XA#*@L25_KLMN@:S\DP41Q*&,TRTJZ3,>_P7_# L@^.>
M4OWO.1YD91WE1VJ39_U?\URN_PT76XY=*668>N%-(NZ7] J[6L-_HSGHR#%Z
MU2$;)Y^:% N;+4V!^00]9#V\1Z]"MWGD0LD-(X@#04,8$B<@UCQ^)JYJ"7H2
M7_*MGA5><,,S+.R::I,OI8\H'&ZZQI+'PPVW+0P%^/@+T*+="OU\ZG8Z_BKB
MW[#=()/"7G8=B-(&MQ:L>+.2.M!]"IY<-XI9VP$18@#&<P9/H.OAGG<P9N[7
M=IF<MTI]MG>#\QCV!W;?[?DS)OL7!H('+RGE<S/#P"+5]W% "J2-3SQ2R* Q
M4,)$:0UNDB8]]H6AD> B9)1GB2)<UW$V^1;$L%W@#)$?TIX@Z E%&\%1J]>V
MH5&X$G :*K<G:NM.A%D/BD:;-V:#TX8V0G*%\;5'676E'Q.7$B<,FX8S:X+=
MTS0+QU?5J'!4;52KCEV/J8UPHUT@Z_#2QN\NL,AK4]4P35/O4C!-NJ9CD*FV
M)<)RE!JA ?1NZ#C%1Z^I)3./CV]';93C14-#A7Z-'&%K.:R7A<DW,$"EY6JX
M6EXCV?YN@]O%[Z#$=U"8JX9+\0.P *.$2-\@EM$JQQ=+GUZ*H4KS@4PZ5K>2
MR,3&"@7:&.$]<:;FRJ\;)AB"T1%<=+FLJ>L-#.]3S[$]?<BQW2G'MM'CG@]K
M# AI V]?8440L8A&+R(0,'6-@DT)WPWL3FR:/@0U]QG9#OC0NYKZT%.R1CST
MZ-AHI#I\R#9&[I@"H/CP<[J-CCN$PY,FX10'GCL1P0ZZ,U24/CS,R&$1'#B_
M]^L>D [Q"3T2>&YKA,I>J$*&I>[:L3V13N[V^CE%Y#2<#W.WBE(ZH+2NO]7=
MY''BB-*'J05T\DCZ>$^7J<-*>Z#E NNJ!_T6D!]'\XN<T\V;&&P^FHK$*!#?
M\RX=&XXH8KI[D&_B\3J<SHZ.[U*I3I[,S'SV^1YN1+B8E:MTZ![G6?0DBPR*
M0*2A6!GKNNJV>.^?A'W/+"5BB $TK//B ^**B'07-F0YDG>VC:\TW& *;JM3
M'"=I)*#/"<)\3@3@DPC"YPFX9[-GQ]0C]=>';?21F[_?[E#(QXO,J7HC^7%3
MYN!,!^V"<-"TAW+7F%2Y@L@B(S)XU/Q'EGXU4S=,/WU^\O3YM/)(1(_X@B=/
M@9%C-RZ5I\^2'[L6]:E'J;RF4'K,H^*8.ZZYU]E9XL W^^YQ5+:WF;KS]/12
MW&^T.+4H"W2%:6B)O-$Q&F+7L^8]4<=7]<KFK6M?P%/@&%O)5(\K+&E'1E9P
M=L>O=('6T4O9A$>579AM8Q.BIF.\(9G@[*_77-N!P<[PX]6(^0Z_=?<@3ASK
M [ >AH-A<*WIP*$?U9DP=>/@TQ<GCZ<%1XRV+9UZ2]VW)WM$5K69NE_P] >
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M\:2ZMK]Q:<3\&OJ:@1-P3=^/D,7OH;#B#Z/\-0YLS3X>.;4D.K_S=3L44'!
M8:J%K%/JLAI$C#BF36?>R);DFNC"8? "[Q:,\H:=6I\<Y(EPV(^@[0NDYG)
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MG#8>"97F=Z\D"ORI%MRD-5K+47YB13TZ;-GPU?UZRR ^&YV.>1_P<LV;#L9
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MMD3+;1I?T\?-=QP9BYHD3Y "1N;L BUO;2N$=CJUGUG)[9)SYIT\_?S%4RX
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M)IKBMX^3KV??G^^:JO-,[=@XC)+><AK@Q6,1L/9]D !/S:D&#2'G)7&WL+*
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M46 S"U8I>2W&S1Y"3*9F*\3M<6]T-=0'J:@8CV P,RJ1,<,=._:7K,H6K]S
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M=&NL Z *8[@F+<.G2KIG#+G]0) A--0C01Z0]CL+F!'6&"5I+::*M!^UJV#
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M]!>"#- V6:V59.$1@"[Z IS5<(C=,'S$96JL2[%0J.6<+T,=@64?7[&:W^;
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MNV0^%[O=\+D.EMJ-7<+3/5^FS,5B>[/.E Y'#+!,/83/F"RB'(U3@^Y!+]Y
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M48;N2' @$8:>2,W[0%,.<H01$0Q/MHK$3K9"YON"21#8"%<2F]7Q K2=DP&
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MG%8Y_@W7![O0'S"K*JJ;E<=!?P=^2J*>HL.@W(R:)FP@8'(.&(&P"4("K"'
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M= I$W!=GY[VW[_L(9_=\T/NM*R[?=<[7%.+^X.+DW^+B<M"[.!>=WSM7IPN
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M3^W]NF_T5VRM>E?G'<73RCW^';.M+[XLV_IT&/MS^&><3\(W_P-02P,$%
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M:1E#63G1K2H474-+D"F-JV*KYL%:ZZZ(HLUF$VZFH9"K*(WC)+K]LOSAH,&
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MZ/LW[%<T7K#=\Z,E=(;=9B\F?P!02P,$%     @ 88H(6<%3T.C_"0  ?50
M !4   !P971S+3(P,C0P.# X7VQA8BYX;6S-G&]OV[H5QM_W4W#9FPVXK$6*
MDJBBS467VP[%<MN@27$O-@P&Q3^)4%L*9*5)OOU(V4ZL6+))RE;W)G$<^CSG
M.>'/Y*$4O_WU83X#/V2UR,OBW0EZ'9P 6?!2Y,7UNY-O5Q\A/?GU]-6KMW^!
M\,]_?#T'OY7\;BZ+&IQ5DM52@/N\O@'UC01_E-7W_ <#%S-6J[*:0WC:O.RL
MO'VL\NN;&N  D_6P]6^K-S@)%%<"0YFJ%!(4A3"3E,& $RF1(EP(_,OU&Z6P
MC#F.8(KC"!)!$:0,<TBRD*<)S@*9B2;H+"^^OS%?,K:00-LK%LV/[TYNZOKV
MS61R?W__^B&K9J_+ZGJ"@R"<K$>?K(8_;(V_#YO1*$W32?/;IZ&+O&N@#HLF
M?_Y^?LEOY)S!O%C4K.!&8)&_631/GI><U4W5]^8%>D>8G^!Z&#1/081AB%X_
M+,3)Z2L EN6HRIG\*A4PW[]]_=0KF4[,B$DAK\W?]D)6>2DN:U;5YRR3,YU]
M$ZU^O)7O3A;Y_'8FU\_=5%)UAYU552NJR3(U6:+89/G7/K')@/0/E&^]G>L!
MDFOL?CY4CKMJ^OE@Z5[I=PAY_(0W9 :GO)Q0'PHQUMQ]DAJ<^O$S/M2T*&LV
M&V%:/,MLI#PS3YSK1RL9$VC'FVFCLWKKWDA5/M2R$'+Y;MD*#7+Q[D0_F@J9
M3R\EOZOR^O'# []AQ;7\S.9R&DD:8!K$4+&4ZC6)!5 O12FDH:1)I$@0TF1:
M/\WIJ2S@M\NU?*.Q6^#$P5G=0V@E%^5=Q9=KFQ8UZ_HRC].U)%AK B/Z=O*<
MGD=-9D=W.CNFR9*W L_,(EU6+YV4?*^3YTF_T%8:&PO)7U^7/R;ZI=H.#LT#
M:!XT<[TWX&3KK_"^6F?)*KZG9*L1$U[J_<=M#5O54U4YM[-3EW9_P&79M.@)
M*"LA*[VG[##0.8T0SJ[R>B:GE 42)R30M:&QWN!% M)(8IA%'*>1$AG#TA6K
M=? C(]5H@%(!A/^6_1VLU=V9>BJ&/4\^%MU8<G7G!=-+&X- >@HV.D0O;70!
MM#7&'9X_=!R]@)V5\_E=D2\[BL54\R,E511*%&-(<!C!C.LE*D"I;J)BSDEF
MO3!U*AP9HY4F:(O:4]1=E?TH#?;JQI.C32><=EKQ8JH[XFA@[32T2=?N@>Z(
MF49]=G%3%O+SW3R3U12%G&5I(J'D9GT*N((,9QBF-.5Q3'#$TM26KI?!CPQ6
M(P<:/; 4M(=JJP[[>1KBS@TE!V-.&/4Y\")H*]AH\/39V.2F=XP[,E<5,R>(
MEX_SK)Q-.0Z4E'KY85(DD$@90"IC_85G O,$XQAA6UY:D8^]F5MJ@:68/2AM
M]_LI\?;DN'NSL^.$1V?J7FRT(XT&1J>!32JZ![@C\:&H]8[O4\'+ZK:LFD7I
MLF:U/"OOBKIZ/"N%G(9I+#*D"$R)C"!!FA;*$(9!@C-.J0K"(+(%Q4+OR/@L
M,P"M%'X!31*Z:F"5"#"9V+-E4\;]Q!VX.&X<'J(N3I ZN/5"UR;^:$ [F-W$
MW.5EOO"_%T)/BT43]TMU494_<FUGJC(9$1%QB)$2D$2QICZ0F7D4A2Q188:(
M&_7=0N/@OM+>F-!K?5?(>\IE2_?P(GAA[>'? ^;=Y@90W!-X9'QWV]OF=L]X
M=V O*FGZ1ZFCF*O=GQ:+.UE=F0L%U1>E=._#$BK#+*,P5$F@][2!7K15%$)!
M8XF4BAF)K:'=)W9D<+4\Y!OZ8)D 6&8 FA3LV=U;N?W\'K(>;@P/*H43QK8>
MO5#>&WPTG&UM;B)M_1IWK-=WKSQ=L/U-OV%,.1*,1$3!0! )"=549TR$D'">
M4IJJ5--LRW*GPI$!?KHG9RD*M"HPLO;0=M=E/ZF#W;KAZ6S4"<F=9KPX[(XX
M&GP[#6T2MWN@.V9GY0]9O<\6=<5X;3&-6N./-WT:&?"?M=!_#S-M.I/WFB[M
M2*--DTX#F].C>X!O%_1A+JOKO+C^9U7>US?ZG?Z6%8]3P<,PHY)!$6(%B3)G
MZC1*H8RR*$J$(F'FV 1UZHS3 ZVEP5(;K,1=&Z#N2MGV/X/]>[4_KM8]>I^=
MQ@:T/MUQ1^Y\=IK;;GQV#Q_<]VSNVY,(2<)0!%4<Z+T12R5D"DDH!56"$LD%
MMK[JU2\S=J]SD"9G4'OS<QJ;HW<T1^IE_A^Z&+?^Y3"=RV4YRWE>:]1_UWNS
M*F>S*1$!22D)(&>409+R%.H5E,, 9;%@H50\Y=:W26V%/S*(SX)@K>APD]1V
M,?9C-\RB&VXN[MQNDNHUX7>;U':X\6Z4ZK72NE6J?Y1'7V*."BO)FJM$"9<L
M23""(D!([SA##M-(8*A$%@:"H42_W!:?S<!'!N>L.6366HX7SEK>+5HR3T>.
M'9F=&;=^K"-SOW9L,]!XW5A'^JUFK.OW Z](792+FLW^G=\VDR..21 HS& <
M)\+<?AO -(PXC!@.,L:Y7G*8U_6HELS(5Z.6VD"+>UUP[BR4;2<VU+Y7(^;L
MW/\J5*>QX=>@VF%_SA6H3FN]UY^Z1_L?4U_IETXI(2$-A-GFL1@22CC,9$PA
MI@$*4L9E%#J?3IO 8QU*&RWWD^C&NOT!M*LASW/GG5Z\#ILW$Q]TQMP$&OUH
M>3/]KA/EUN_=07BO8P@3Y^.,74\Q2YFVSF$<<O-_(8I QEBF&Q[*A,*"<F2]
M8VM%/C(*3UK B-FST':_'P9O3VXT6-IQPJ$S=2\>VI%& Z+3P"81W0-\-VYG
M.E#%9I\*(1_^)1^G 1**9J%N9I(TA"26$F8BC6"B4!83%@O$K='H5!AGN[82
M!8TJT+*N^[27=;'=H@UPZ[4[LS?JL2WK,3-@1_8RXLB;L1Y#V_NPOH&^F'W,
M9^M_=HBCF- 01^:TS1Q_DPRR* YA$G"44,50)$,WPIZ#CP.7T7/^IX^M.M@2
MY>?."R8;8QX8;3L80-!&L)'AV;:QS4W'F(%'"N:8XDMU5=X7TU1QBDF S8J$
M];8-9Y B(6#(S;:-1X)SY76>\*PQ\F%"<VQ55L!(>YXD;-3'\1C!S_6P,P0K
MP_X'"-N6AI\>;,3\.4<'VZ9ZSPTZAOKB=\4>/@F]"N9J]9^/J[=M%8I$*HZA
MY$D$"44:0DX(3$6*XCA@2 KKJ[<[E<9!48N#MKKGRM97+ULH#U %+S3="^"!
MYQYS R#MBSPRJGL,;@.[[P4#5\W5M_.\D&B*4AGQB$60A3&'!&,,TT@W=@%6
M8<!8D 21]?7=7I615\[5 V"TP9?"]QR^52?']=/7_; 5U-JX_RK:96SX.MJ*
M^G-6TBYCO6MIYV!?++_*Z]S<]EC4S6<;A6&($$8$HM1\WE,D$\@0-<LISG#,
M@Q11QU.6ML X,#YK.G[>4V=-;.GS=^H%GJU)#]RZG0P@[47 D2'KMK/-5\^X
M/K0V*ZYA_'[Z:OU,OORTRM-7_P-02P,$%     @ 88H(6:8([+:N!@  Y#
M !4   !P971S+3(P,C0P.# X7W!R92YX;6S5FFUOXS82Q]_G4_A\;X\QGT12
MP29%+MT]!)=V@]T4+>Z-P8>A+526#$K9)-_^1DK<)IM-*T0&HGWC!YG2#/_S
M,SDSTKL?;C?E[ NDIJBKXSD[I/,95+X.1;4ZGO]R]8&8^0\G!P?O_D'(;__^
M=#'[L?;7&ZC:V5D"VT*8W13M>M:N8?9KG7XOOMC996G;6*<-(2?]:6?U]BX5
MJW4[XY3+W;#=K^F(:QI]#)Q 'G,B62:( V,)]1* 1>E#X/]:'<7(07F>D9RK
MC,A@&#&6>R*=\+GFCH(+_47+HOK]J'MQMH$93J]J^J_'\W7;;H\6BYN;F\-;
ME\K#.JT6G%*QV(V>/PR_?3;^1O2C69[GB_[7/X8VQ;<&XF79XK>?+C[[-6PL
M*:JFM97O##3%4=,?O*B];7O5_]:OV8LCNF]D-XQTAPCC1+##VR;,3PYFLWLY
M4EW")XBS[OV73^=/3#)#Z1;:#83FT->;13=F<58C$^AM?W9[MX7C>5-LMB7L
MCJT3Q.,YGM>0+JS44-/9_.?]B8L_36\3-,A+/]4+//!P?F?E56[ ;0M5@/O9
M[8R4M7\RJ.RTK?\XL[0.RO[H,D"Q[*]ZZIHV6=\NM8Y&>:E(%KP@4EA#3 B6
M6.I"D. A:/YTUIW7#;K=AZ(!?[BJORSPPA@2+KH/G22BE^.9N7MI7N?W[K]W
MA6.73.GH 03)M#+X+\"PFRPXDELK!/X]N(S9*+<?6WOJ]>.0GB8_JU. A(O'
MSIQ-_EEXGV+[,&*QM0DO1/RZ*,/N[)CJS3YBU=9[4.X^+.CN?(:SCI 2A(O[
MJ+PXN7YF+2ZIT(_<1\0O(15U>%^%'W'-78+A1EFJ"7"AB.1,$:-M))G/#?5Y
M)K1@>PG]$[.#&.#39^#U6KXQ#.^KMFCO/L&JZ)2HVI_M!I99Q@./+A*>=]NB
ML)[8''="ZG)+<XKJ*!C%PK>L#D)!3!>%T4I.@H1SS-/2MDZ]\)]1?SBKKZLV
MW9W5H0.;JN!-)#E5CDB?X70RK8FB@.N<429F<@]@_*43@SB14^=D?SI/ IL/
M10D_7V\<I*717F%V;=%MCKIH)8D1FA/OE?0BL!C9/ACYT^(@(+*I _%*!2<1
M_2M[>QY0JR(6]^7'PT0BUD_,.$\R3(B(C.!)KBV07 HOE &LTM0>4'C!_" N
MU-2YV(>VDX#D- 0,0?/PAE4;L*7US&7<H_^4H30A]\1)$X@-(0CJ.&BA]P#(
M-TP/@D-/'8ZQFDX)C#/\^#%=U3?5TELKO0N*:,IP^XMYQ 4P2 *9CC'RS#H]
MKA9YP? @*,QW L4K]9P2$GU>]#%=IOI+47E8RL!S+G$*RF-]+4V7%AD=B&*Y
MR*W+&!-^?UQ\97T0'/EW L<89:=$R&7=M+;\7['MT^9 @2J-B1-3KIM%SDAN
M<#YY=-[BH3RG>]Q.GM@>ULRBWPD>KY?UC>'H%KW3!/:^BJ(T2$X%.MI54<PJ
M8KCP1'B;,9%G&=AQW<S'UH8!,.%VYJNE>^.0=[<\RLMU7>W*I\P8ESLKB94X
M >D 9^'1=RJMH1&39JWHJ+!_;7%8Z"?<Q1PEX1N'_]=4M"U49_5F<UT]E$C-
MTL@85$3?1?#(KU"4.(40=_>4O!!*"9J/8N";9H>!,.$>YG@QWYB&SW59^*(M
MJM5/F."DPI9+W*FLY%*3X( 2F0E&7'2"1$>I8R 4'XG"<YO#.)APCW*DC&\,
MP66"CF# Q+:_/]?=VDT?(_JQU,I[D"H2:KI*B/&,&!\HH1YT]+BJ23]N;WC9
M]C H)MRGW).LTX+CO&FN(3V>"];#F.Y"(%P+!-UZ0ZP 2QS@=^J48&Q<D?EW
M'@P#9<*-R[U*_-8;"OAKW!3O&'=715O"TF MS *N@\KP@.N@5R1W@(NAT]*Z
M/.BQ/8BO+0[#8<*MRE$2OG'XKY+MGEK[?+=Q=;FD6.Q*1BU1#&F5(7/$.&40
M8P_"B>YQ,3<J]D_,#0O\A-N1KQ=O$BVF]QM(*_3_/ZF^:=>XHFUM=;?,(D-
M3=<'D3@-JCW);9\698H*;SSP<4V%OS ^C(C)]R#'"SL)/LY0LF3+<]S7;O\+
M=TL1*'@E+.&,=G?DG"0NZUZ8I5([F;,8]T#&5V:'/4$U^<;C&#'?F(933')"
ME^A\*.UJJ3.=><TBX59AB>RC)#8P19C,,XHEE.0P[O&')^:&17_"7<?7BS>1
MQ/#]K5_;:@7]XUXJ<&L<)C71,,QL#,,ZR&A*,IDYGT5%G;-[20X?6QW&P(3;
MCZ.EW!L*[Q;/-+S  R<'#S]T+]U#\2<'_P=02P$"% ,4    " !AB@A9P_+M
M:RP1  !V9   '0              @ $     97AH:6)I=#$P,3%F;W)M;V9R
M<W5A=V%R9"YH=&U02P$"% ,4    " !AB@A956Y:NYE/  "+  ( '@
M        @ %G$0  97AH:6)I=#$P,3(P,C1O;6YI8G5S:6YC96XN:'1M4$L!
M A0#%     @ 88H(62D4X&P!$P  Z8(  !T              ( !/&$  &5X
M:&EB:70Q,#$R9F]R;6]F<'-U87=A<F0N:'1M4$L! A0#%     @ 88H(64)K
M$LJ($@  3FD  !@              ( !>'0  &5X:&EB:70Q,#$S9F]R;6]F
M<G-A+FAT;5!+ 0(4 Q0    ( &&*"%D=19K&%1<  *.3   >
M  "  3:'  !E>&AI8FET,3 Q-&9O<FUO9G-T;V-K;W!T:2YH=&U02P$"% ,4
M    " !AB@A9-PBLA 8-  "B40  '@              @ &'G@  97AH:6)I
M=#$P,FYO;BUE;7!L;WEE961I<F4N:'1M4$L! A0#%     @ 88H(62IL:N2Z
M%@  :>4  !$              ( !R:L  '!E=',M,C R-# X,#@N:'1M4$L!
M A0#%     @ 88H(68F0'+YM @  >0<  !$              ( !LL(  '!E
M=',M,C R-# X,#@N>'-D4$L! A0#%     @ 88H(6<%3T.C_"0  ?50  !4
M             ( !3L4  '!E=',M,C R-# X,#A?;&%B+GAM;%!+ 0(4 Q0
M   ( &&*"%FF".RVK@8  .0P   5              "  8#/  !P971S+3(P
D,C0P.# X7W!R92YX;6Q02P4&      H "@#$ @  8=8

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>pets-20240808_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pets-20240808.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001040130</identifier>
        </entity>
        <period>
            <startDate>2024-08-08</startDate>
            <endDate>2024-08-08</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001040130</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-08-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">PetMed Express, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">FL</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">000-28827</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">65-0680967</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">420 South Congress Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Delray Beach</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">33445</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">561</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">526-4444</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">PETS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
